Source Class, Target Class, Score
Disease caused by Coronaviridae,primary infectious disposition,0.6139344262295081
Disease caused by Coronaviridae,process of establishing viral infection,0.6071428571428572
Disease caused by Coronaviridae,virus adhesion susceptible cell,0.6435483870967742
Disease caused by Coronaviridae,single-stranded DNA virus,0.6642857142857143
Disease caused by Coronaviridae,SARS-CoV-2 disorder,0.65
Disease caused by Coronaviridae,virus release stage,0.65
Disease caused by Coronaviridae,virus translation stage,0.6351851851851852
Disease caused by Coronaviridae,subclinical infection,0.6038461538461539
Disease caused by Coronaviridae,COVID-19 mortality rate,0.6351851851851852
Disease caused by Coronaviridae,double-stranded RNA virus,0.6821428571428573
Disease caused by Coronaviridae,collective pathogenic disposition,0.590625
Disease caused by Coronaviridae,infectious disease endemicity,0.65
Disease caused by Coronaviridae,infection,0.575
Disease caused by Coronaviridae,establishment of localization in virus host,0.6256756756756756
Disease caused by Coronaviridae,negative-sense single-stranded RNA virus,0.6753521126760563
Disease caused by Coronaviridae,infectious disease course,0.6642857142857143
Disease caused by Coronaviridae,communicability start process boundary,0.6239130434782608
Disease caused by Coronaviridae,infectious disease mortality rate,0.684375
Disease caused by Coronaviridae,virostatic disposition,0.6009433962264151
Disease caused by Coronaviridae,SARS-COV-2 adhesion disposition,0.6112903225806451
Disease caused by Coronaviridae,exotoxin disposition,0.5676470588235294
Disease caused by Coronaviridae,virus synthesis stage,0.6230769230769231
Disease caused by Coronaviridae,invasive disposition,0.6264705882352941
Disease caused by Coronaviridae,disposition,0.5928571428571429
Disease caused by Coronaviridae,viral disease pandemic,0.6764150943396227
Disease caused by Coronaviridae,establishment of a clinically abnormal colony,0.6342105263157894
Disease caused by Coronaviridae,nursing-home acquired infection,0.6274193548387097
Disease caused by Coronaviridae,local infection,0.5804347826086956
Disease caused by Coronaviridae,fungistatic disposition,0.5981481481481481
Disease caused by Coronaviridae,disease surveillance objective specification,0.6766666666666665
Disease caused by Coronaviridae,cidal agent disposition,0.6166666666666667
Disease caused by Coronaviridae,COVID-19 incidence rate,0.6166666666666667
Disease caused by Coronaviridae,COVID-19 epidemic,0.5958333333333333
Disease caused by Coronaviridae,complex infection,0.575
Disease caused by Coronaviridae,immunosuppressive disposition,0.6166666666666667
Disease caused by Coronaviridae,endotoxin disposition,0.5846153846153846
Disease caused by Coronaviridae,source of infection site,0.6318181818181818
Disease caused by Coronaviridae,infectious disease sporadicity,0.6795081967213115
Disease caused by Coronaviridae,coronavirus disease course,0.6605263157894737
Disease caused by Coronaviridae,disordered virus,0.6627659574468084
Disease caused by Coronaviridae,infectious disease control objective specification,0.6475308641975309
Disease caused by Coronaviridae,viral disease course,0.6852941176470588
Disease caused by Coronaviridae,infectious disease epidemic,0.656896551724138
Disease caused by Coronaviridae,parasiticidal disposition,0.5928571428571429
Disease caused by Coronaviridae,neurotoxin disposition,0.5820754716981132
Disease caused by Coronaviridae,infectious disease,0.6336734693877552
Disease caused by Coronaviridae,intracellular infection,0.5981481481481481
Disease caused by Coronaviridae,infection incidence rate profile,0.6246031746031746
Disease caused by Coronaviridae,source of infection,0.61
Disease caused by Coronaviridae,T cell receptor complex,0.6166666666666667
Disease caused by Coronaviridae,acquired immunodeficiency,0.6285714285714286
Disease caused by Coronaviridae,static agent disposition,0.6136363636363636
Disease caused by Coronaviridae,viral disease epidemic,0.6764150943396227
Disease caused by Coronaviridae,incubation end temporal region,0.630327868852459
Disease caused by Coronaviridae,reverse zoonotic disposition,0.6194915254237288
Disease caused by Coronaviridae,COVID-19 disease course,0.6722222222222223
Disease caused by Coronaviridae,viricidal disposition,0.5846153846153846
Disease caused by Coronaviridae,viral disease,0.609090909090909
Disease caused by Coronaviridae,communicability start temporal region,0.6117647058823529
Disease caused by Coronaviridae,disease,0.6342105263157894
Disease caused by Coronaviridae,opportunistic infectious disposition,0.5992537313432835
Disease caused by Coronaviridae,site of infection,0.5958333333333333
Disease caused by Coronaviridae,positive-sense single-stranded RNA virus,0.6753521126760563
Disease caused by Coronaviridae,collective disposition,0.5820754716981132
Disease caused by Coronaviridae,source of infection role,0.6318181818181818
Disease caused by Coronaviridae,hospital-acquired infection,0.6224137931034482
Disease caused by Coronaviridae,primary infection,0.5958333333333333
Disease caused by Coronaviridae,acute infection,0.6239130434782608
Disease caused by Coronaviridae,COVID-19 disease incidence proportion,0.6705882352941177
Disease caused by Coronaviridae,infection incidence,0.63
Disease caused by Coronaviridae,coronavirus disease,0.69
Disease caused by Coronaviridae,viral adhesion disposition,0.6078947368421053
Disease caused by Coronaviridae,virus disorder,0.6277777777777778
Disease caused by Coronaviridae,pathogenic disposition,0.5820754716981132
Disease caused by Coronaviridae,virus aggregate,0.6239130434782608
Disease caused by Coronaviridae,virus generative stage,0.619811320754717
Disease caused by Coronaviridae,infectious disease incidence rate,0.66875
Disease caused by Coronaviridae,community-acquired infection,0.6194915254237288
Disease caused by Coronaviridae,adhesion disposition,0.6068627450980393
Disease caused by Coronaviridae,infection start temporal region,0.6112903225806451
Disease caused by Coronaviridae,infectious disposition,0.619811320754717
Disease caused by Coronaviridae,virus replication,0.5958333333333333
Disease caused by Coronaviridae,chronic infection,0.5958333333333333
Disease caused by Coronaviridae,zoonotic disposition,0.5676470588235294
Disease caused by Coronaviridae,bactericidal disposition,0.5954545454545455
Disease caused by Coronaviridae,disorder,0.6294871794871795
Disease caused by Coronaviridae,acute respiratory distress syndrome,0.6166666666666667
Disease caused by Coronaviridae,infectious disease prevalence,0.65
Disease caused by Coronaviridae,lower respiratory tract disease,0.6112903225806451
Disease caused by Coronaviridae,primary infection role,0.619811320754717
Disease caused by Coronaviridae,acute infectious disease course,0.6435483870967742
Disease caused by Coronaviridae,infectious disease control strategy,0.6772727272727272
Disease caused by Coronaviridae,communicability end process boundary,0.6291044776119403
Disease caused by Coronaviridae,collective resistance disposition,0.590625
Disease caused by Coronaviridae,subclinical SARS-CoV-2 infection,0.6087301587301588
Disease caused by Coronaviridae,disease course,0.7166666666666667
Disease caused by Coronaviridae,communicability end temporal region,0.6166666666666667
Disease caused by Coronaviridae,simple infection,0.598936170212766
Disease caused by Coronaviridae,infection end temporal region,0.6333333333333333
Disease caused by Coronaviridae,infectious disease incidence,0.6533898305084747
Disease caused by Coronaviridae,infectious disease pandemic,0.656896551724138
Disease caused by Coronaviridae,disease transmission model,0.6956140350877194
Disease caused by Coronaviridae,virus attachment stage,0.6009433962264151
Disease caused by Coronaviridae,process of establishing an infection,0.5992537313432835
Disease caused by Coronaviridae,infection incidence proportion profile,0.6384057971014493
Disease caused by Coronaviridae,incubation end process boundary,0.6435483870967742
Disease caused by Coronaviridae,infection incidence profile,0.6224137931034482
Disease caused by Coronaviridae,respiratory system disease,0.6078947368421053
Disease caused by Coronaviridae,respiratory droplet virus fomite,0.6404761904761905
Disease caused by Coronaviridae,incubation start process boundary,0.6375
Disease caused by Coronaviridae,latency end process boundary,0.6364406779661017
Disease caused by Coronaviridae,SARS-CoV-2 incidence rate,0.6464285714285714
Disease caused by Coronaviridae,infection prevalence,0.6068627450980393
Disease caused by Coronaviridae,infectious disorder,0.65
Disease caused by Coronaviridae,systematic infection,0.6068627450980393
Disease caused by Coronaviridae,infectious disease incidence proportion,0.6642857142857143
Disease caused by Coronaviridae,double-stranded DNA virus,0.6642857142857143
Disease caused by Coronaviridae,B cell receptor complex,0.6166666666666667
Disease caused by Coronaviridae,secondary infection role,0.65
Disease caused by Coronaviridae,enterotoxin disposition,0.5796296296296296
Disease caused by Coronaviridae,chronic infectious disease course,0.6375
Disease caused by Coronaviridae,virus uncoating stage,0.6423076923076922
Disease caused by Coronaviridae,infectious disease lifetime prevalence,0.6528985507246376
Disease caused by Coronaviridae,appearance of disorder,0.6386792452830189
Disease caused by Coronaviridae,toxin disposition,0.575
Disease caused by Coronaviridae,secondary infection,0.63
Disease caused by Coronaviridae,virus penetration stage,0.6166666666666667
Disease caused by Coronaviridae,infection start process boundary,0.6404761904761905
Disease caused by Coronaviridae,transmissibility disposition,0.6025423728813559
Disease caused by Coronaviridae,acquired immunity to infectious agent,0.6411764705882353
Disease caused by Coronaviridae,virus host,0.5719512195121951
Disease caused by Coronaviridae,virulence factor disposition,0.6364406779661017
Disease caused by Coronaviridae,latency end temporal region,0.6396551724137931
Disease caused by Coronaviridae,invasion disposition,0.6068627450980393
Disease caused by Coronaviridae,infection incidence rate,0.6318181818181818
Disease caused by Coronaviridae,virus,0.5333333333333333
Disease caused by Coronaviridae,subclinical virus infection,0.6396551724137931
Disease caused by Coronaviridae,extracellular infection,0.5981481481481481
Disease caused by Coronaviridae,subclinical coronavirus infection,0.684375
Disease caused by Coronaviridae,parasitostatic disposition,0.5903508771929825
Disease caused by Coronaviridae,metastatic infection,0.6068627450980393
Disease caused by Coronaviridae,infection incidence proportion,0.6139344262295081
Disease caused by Coronaviridae,cytotoxin disposition,0.5846153846153846
Disease caused by Coronaviridae,long-term non-progressing infectious disease course,0.5963414634146341
Disease caused by Coronaviridae,fungicidal disposition,0.5820754716981132
Disease caused by Coronaviridae,coronavirus disorder,0.6852941176470588
Disease caused by Coronaviridae,latency start process boundary,0.630327868852459
Disease caused by Coronaviridae,bacteriostatic disposition,0.5903508771929825
Disease caused by Coronaviridae,virus transcription stage,0.6464285714285714
Person,molecular entity,0.5863636363636363
Person,anatomical entity,0.5369565217391304
Person,establishment of a clinically abnormal colony,0.5284313725490196
Person,organism population,0.61
Person,geographical entity,0.57
Person,immunosuppressed organism,0.6112903225806451
Person,pathologically immunosuppressed organism,0.558695652173913
Person,geopolitical entity,0.57
Person,T cell receptor complex,0.553448275862069
Person,resistant entity,0.5863636363636363
Person,immaterial entity,0.5804347826086956
Person,drug-based immunosuppressed organism,0.569047619047619
Person,directive information content entity,0.5452380952380953
Person,herd immunity to infectious organism,0.569047619047619
Person,information content entity,0.54375
Person,immunodeficient organism,0.55
Person,material entity,0.5928571428571429
Person,organism,0.5928571428571429
Person,lower respiratory tract disease,0.5581081081081081
Person,division of geopolitical entity,0.5310810810810811
Person,colonization of human,0.524074074074074
Person,B cell receptor complex,0.553448275862069
Person,establishment of localization in human host,0.5316326530612244
Person,infectious human pathogen,0.5790322580645162
Person,descriptive information content entity,0.5636363636363636
Person,realizable entity,0.5369565217391304
Person,designative information content entity,0.5409090909090909
Person,entity,0.6166666666666667
Person,extended organism,0.5804347826086956
Person,organism substance,0.575
Person,susceptible organism,0.6038461538461539
Person,immunocompetent organism,0.5833333333333334
Agent,passive immunity to infectious agent,0.5719512195121951
Agent,humoral immunity to infectious agent,0.5719512195121951
Agent,COVID-19 mortality rate,0.5214285714285714
Agent,susceptibility to infectious agent,0.5782051282051281
Agent,infectious disease course,0.5166666666666666
Agent,symptomatic carrier,0.5333333333333333
Agent,sterilizing immunity to infectious agent,0.5611111111111111
Agent,infectious disease mortality rate,0.5289473684210526
Agent,establishment of a clinically abnormal colony,0.53
Agent,intermediate host,0.5863636363636363
Agent,adhesion factor,0.65
Agent,asymptomatic infectious structure carrier,0.5152173913043478
Agent,infectious agent colony,0.6285714285714286
Agent,drug susceptibility of infectious agent,0.5636363636363636
Agent,cidal agent disposition,0.6285714285714286
Agent,COVID-19 incidence rate,0.5571428571428572
Agent,coronavirus disease course,0.5145161290322581
Agent,symptomatic carrier role,0.5189655172413793
Agent,viral disease course,0.53
Agent,infection incidence rate profile,0.5310810810810811
Agent,T cell receptor complex,0.5214285714285714
Agent,static agent disposition,0.6224137931034482
Agent,incubation end temporal region,0.5642857142857143
Agent,invasion factor,0.6
Agent,COVID-19 disease course,0.5214285714285714
Agent,symptomatic infectious agent carrier,0.5719512195121951
Agent,function,0.6038461538461539
Agent,passive immunization against infectious agent,0.55
Agent,directive information content entity,0.5475609756097561
Agent,innate immunity to infectious agent,0.575
Agent,information content entity,0.5790322580645162
Agent,polymerase chain reaction,0.5833333333333334
Agent,static agent,0.7441176470588234
Agent,infectious disease incidence rate,0.5552631578947369
Agent,biological vehicle,0.5369565217391304
Agent,pathogen vehicle role,0.6038461538461539
Agent,acute infectious disease course,0.5611111111111111
Agent,pathogen transporter role,0.6166666666666667
Agent,immunization against infectious agent,0.569047619047619
Agent,pathogen transporter,0.65
Agent,communicability end process boundary,0.523170731707317
Agent,infectious agent population,0.60625
Agent,disease course,0.5552631578947369
Agent,communicability end temporal region,0.55
Agent,infection end temporal region,0.5382352941176471
Agent,pathogen vehicle,0.6404761904761905
Agent,biological vehicle role,0.5214285714285714
Agent,incubation end process boundary,0.5333333333333333
Agent,infectious agent reservoir,0.6112903225806451
Agent,latency end process boundary,0.5409090909090909
Agent,asymptomatic infectious agent carrier,0.569047619047619
Agent,asymptomatic carrier role,0.5166666666666666
Agent,SARS-CoV-2 incidence rate,0.5833333333333334
Agent,infectious agent,0.6880952380952381
Agent,intermediate host role,0.5611111111111111
Agent,symptomatic infectious structure carrier,0.5166666666666666
Agent,B cell receptor complex,0.5214285714285714
Agent,leukocyte-mediated immunity to infectious agent,0.5461538461538461
Agent,active immunization against infectious agent,0.5520408163265306
Agent,chronic infectious disease course,0.5026315789473684
Agent,asymptomatic carrier,0.53
Agent,vaccination against infectious agent,0.5719512195121951
Agent,descriptive information content entity,0.5430232558139535
Agent,infectious agent host,0.6423076923076922
Agent,cidal agent,0.7625
Agent,acquired immunity to infectious agent,0.569047619047619
Agent,virulence factor disposition,0.5409090909090909
Agent,infectious agent host role,0.6112903225806451
Agent,designative information content entity,0.5430232558139535
Agent,latency end temporal region,0.575
Agent,infection incidence rate,0.553448275862069
Agent,action specification,0.57
Agent,virulence factor,0.5928571428571429
Agent,infectious agent generative stage,0.581578947368421
Agent,long-term non-progressing infectious disease course,0.5214285714285714
InfectedNiece,infected population,0.73125
InfectedNiece,T cell receptor complex,0.5888888888888889
Diagnosed With COVID-19,COVID-19 mortality rate,0.6239130434782608
Diagnosed With COVID-19,COVID-19 prevalence,0.6404761904761905
Diagnosed With COVID-19,establishment of a clinically abnormal colony,0.5676470588235294
Diagnosed With COVID-19,COVID-19 incidence rate,0.6239130434782608
Diagnosed With COVID-19,COVID-19 epidemic,0.65
Diagnosed With COVID-19,COVID-19 sporadicity,0.636046511627907
Diagnosed With COVID-19,COVID-19,0.7080645161290323
Diagnosed With COVID-19,COVID-19 pandemic,0.65
Diagnosed With COVID-19,T cell receptor complex,0.5804347826086956
Diagnosed With COVID-19,COVID-19 disease course,0.6239130434782608
Diagnosed With COVID-19,COVID-19 disease incidence proportion,0.6166666666666667
Diagnosed With COVID-19,COVID-19 lifetime prevalence,0.6068627450980393
Diagnosed With COVID-19,COVID-19 incidence,0.6451219512195122
Diagnosed With COVID-19,COVID-19 endemicity,0.6404761904761905
Diagnosed With COVID-19,place closure control strategy,0.5820754716981132
Group,infectious disease mortality rate,0.5026315789473684
Group,infectious structure aggregate,0.5071428571428571
Group,object aggregate,0.5452380952380953
Group,infection incidence rate profile,0.504054054054054
Group,T cell receptor complex,0.5571428571428572
Group,coronavirus aggregate,0.5653846153846154
Group,polymerase chain reaction,0.5166666666666666
Group,virus aggregate,0.55
Group,infectious disease incidence rate,0.5026315789473684
Group,SARS-CoV-2 aggregate,0.53
Group,viroid aggregate,0.5452380952380953
Group,respiratory system disease,0.5145161290322581
Group,SARS-CoV-2 incidence rate,0.5166666666666666
Group,B cell receptor complex,0.5571428571428572
Group,acellular structure aggregate,0.5088235294117647
Group,prion aggregate,0.55
Group,action specification,0.53
Business,process of establishing viral infection,0.5563829787234043
Business,pathogen death process boundary,0.5525641025641026
Business,pathogen birth process boundary,0.5782051282051281
Business,establishment of localization in virus host,0.5676470588235294
Business,communicability start process boundary,0.558695652173913
Business,droplet pathogen transmission process,0.5833333333333334
Business,establishment of a clinically abnormal colony,0.5254716981132076
Business,negative regulation of biological process,0.5724489795918367
Business,adhesion factor,0.5804347826086956
Business,pathogen portal of entry site,0.5310810810810811
Business,establishment of localization,0.5581081081081081
Business,source of infection site,0.60625
Business,process profile,0.5804347826086956
Business,negative regulation of establishment of localization,0.55
Business,immune response,0.6673913043478261
Business,source of infection,0.5981481481481481
Business,incubation end temporal region,0.5552631578947369
Business,invasion factor,0.5804347826086956
Business,entry into host,0.5804347826086956
Business,function,0.6375
Business,entry into host through host barriers,0.5611111111111111
Business,source of infection role,0.575
Business,plan specification,0.5653846153846154
Business,pathogen portal of entry role,0.504054054054054
Business,generically dependent continuant,0.525
Business,polymerase chain reaction,0.5712121212121213
Business,production,0.6166666666666667
Business,contact pathogen transmission process,0.5833333333333334
Business,process boundary,0.575
Business,pathogen portal of entry,0.5125
Business,process that results in death,0.5851351351351352
Business,lower respiratory tract disease,0.5525641025641026
Business,establishment of localization in host,0.5611111111111111
Business,communicability end process boundary,0.5863636363636363
Business,negative regulation of immune response,0.5804347826086956
Business,negative regulation of production,0.523170731707317
Business,developmental process,0.5879310344827586
Business,negative regulation of life-sustaining process,0.5796296296296296
Business,communicability end temporal region,0.5430232558139535
Business,negative regulation of developmental process,0.5653846153846154
Business,infection end temporal region,0.5310810810810811
Business,pathogen transmission process,0.6121621621621621
Business,process,0.65
Business,process of establishing an infection,0.5636363636363636
Business,humoral immune response,0.6435483870967742
Business,incubation end process boundary,0.6038461538461539
Business,innate immune response,0.6166666666666667
Business,incubation start process boundary,0.5963414634146341
Business,surveillance process,0.6642857142857143
Business,symbiotic process,0.65
Business,latency end process boundary,0.5611111111111111
Business,B cell receptor complex,0.5145161290322581
Business,biological process,0.6423076923076922
Business,specifically dependent continuant,0.5475609756097561
Business,establishment of localization in human host,0.5480392156862746
Business,infection start process boundary,0.575
Business,PCR product,0.5026315789473684
Business,planned process,0.6239130434782608
Business,virulence factor disposition,0.5888888888888889
Business,horizontal pathogen transmission process,0.575
Business,latency end temporal region,0.5071428571428571
Business,negative regulation of viral process,0.5863636363636363
Business,organism substance,0.6038461538461539
Business,action specification,0.5571428571428572
Business,virulence factor,0.575
Business,adaptive immune response,0.60625
Business,indirect pathogen transmission process,0.5804347826086956
Business,latency start process boundary,0.5552631578947369
Comorbidity,T cell receptor complex,0.5382352941176471
Comorbidity,B cell receptor complex,0.5382352941176471
District wise statistics,infectious disease course,0.6744897959183673
District wise statistics,establishment of a clinically abnormal colony,0.5949275362318841
District wise statistics,organism population,0.6127906976744186
District wise statistics,local infection,0.6038461538461539
District wise statistics,material processing,0.636046511627907
District wise statistics,infectious agent colony,0.6414893617021277
District wise statistics,infected population,0.636046511627907
District wise statistics,source of infection site,0.6583333333333334
District wise statistics,coronavirus disease course,0.65
District wise statistics,spatial region,0.6078947368421053
District wise statistics,viral disease course,0.6772727272727272
District wise statistics,source of infection,0.636046511627907
District wise statistics,T cell receptor complex,0.5776595744680851
District wise statistics,incubation end temporal region,0.6166666666666667
District wise statistics,temporal region,0.5782051282051281
District wise statistics,COVID-19 disease course,0.6414893617021277
District wise statistics,communicability start temporal region,0.6139344262295081
District wise statistics,one-dimensional temporal region,0.5954545454545455
District wise statistics,directive information content entity,0.6666666666666667
District wise statistics,three-dimensional spatial region,0.6285714285714286
District wise statistics,source of infection role,0.6166666666666667
District wise statistics,acute infection,0.6294871794871795
District wise statistics,plan specification,0.5928571428571429
District wise statistics,zero-dimensional temporal region,0.5928571428571429
District wise statistics,information content entity,0.65
District wise statistics,processed material,0.6404761904761905
District wise statistics,normal resident microbiota population,0.5975409836065574
District wise statistics,infection start temporal region,0.65
District wise statistics,material entity,0.6551282051282051
District wise statistics,process that results in death,0.6386792452830189
District wise statistics,acute respiratory distress syndrome,0.6364406779661017
District wise statistics,geospatial region,0.5963414634146341
District wise statistics,lower respiratory tract disease,0.65
District wise statistics,acute infectious disease course,0.6681818181818181
District wise statistics,communicability end process boundary,0.5833333333333334
District wise statistics,infectious agent population,0.6460784313725491
District wise statistics,disease course,0.6605263157894737
District wise statistics,zero-dimensional spatial region,0.6318181818181818
District wise statistics,communicability end temporal region,0.6025423728813559
District wise statistics,infection end temporal region,0.619811320754717
District wise statistics,incubation end process boundary,0.5954545454545455
District wise statistics,latency end process boundary,0.5846153846153846
District wise statistics,angiotensin-converting enzyme 2,0.5954545454545455
District wise statistics,pathogen birth temporal region,0.5796296296296296
District wise statistics,susceptible population,0.6456521739130434
District wise statistics,B cell receptor complex,0.5563829787234043
District wise statistics,geographical region,0.5895348837209302
District wise statistics,immune population,0.5963414634146341
District wise statistics,active immunization against infectious agent,0.6411764705882353
District wise statistics,chronic infectious disease course,0.6605263157894737
District wise statistics,spatiotemporal region,0.6055555555555556
District wise statistics,descriptive information content entity,0.6596774193548387
District wise statistics,two-dimensional spatial region,0.6351851851851852
District wise statistics,pathogen death temporal region,0.5796296296296296
District wise statistics,designative information content entity,0.6435483870967742
District wise statistics,latency end temporal region,0.6068627450980393
District wise statistics,diseased population,0.6593023255813953
District wise statistics,one-dimensional spatial region,0.6351851851851852
District wise statistics,long-term non-progressing infectious disease course,0.6233333333333334
Disease,primary infectious disposition,0.5581081081081081
Disease,process of establishing viral infection,0.558695652173913
Disease,virus adhesion susceptible cell,0.581578947368421
Disease,single-stranded DNA virus,0.60625
Disease,SARS-CoV-2 disorder,0.6038461538461539
Disease,virus release stage,0.6807692307692308
Disease,virus translation stage,0.6166666666666667
Disease,subclinical infection,0.5571428571428572
Disease,double-stranded RNA virus,0.60625
Disease,collective pathogenic disposition,0.55
Disease,infectious disease endemicity,0.6444444444444444
Disease,infection,0.575
Disease,establishment of localization in virus host,0.55
Disease,negative-sense single-stranded RNA virus,0.5563829787234043
Disease,infectious disease course,0.66875
Disease,infectious disease mortality rate,0.625
Disease,virostatic disposition,0.5879310344827586
Disease,SARS-COV-2 adhesion disposition,0.5552631578947369
Disease,exotoxin disposition,0.5981481481481481
Disease,virus synthesis stage,0.6285714285714286
Disease,invasive disposition,0.5981481481481481
Disease,disposition,0.6722222222222223
Disease,viral disease pandemic,0.6913793103448276
Disease,establishment of a clinically abnormal colony,0.5269230769230769
Disease,nursing-home acquired infection,0.5552631578947369
Disease,local infection,0.5409090909090909
Disease,fungistatic disposition,0.5833333333333334
Disease,disease surveillance objective specification,0.5872549019607843
Disease,cidal agent disposition,0.5833333333333334
Disease,COVID-19 epidemic,0.575
Disease,complex infection,0.5333333333333333
Disease,immunosuppressive disposition,0.5888888888888889
Disease,endotoxin disposition,0.5928571428571429
Disease,source of infection site,0.5790322580645162
Disease,infectious disease sporadicity,0.6391891891891892
Disease,coronavirus disease course,0.6621212121212122
Disease,disordered virus,0.6673913043478261
Disease,infectious disease control objective specification,0.5728070175438597
Disease,viral disease course,0.7092592592592593
Disease,infectious disease epidemic,0.6558823529411765
Disease,parasiticidal disposition,0.575
Disease,neurotoxin disposition,0.5879310344827586
Disease,infectious disease,0.73
Disease,intracellular infection,0.5833333333333334
Disease,infection incidence rate profile,0.5525641025641026
Disease,source of infection,0.5653846153846154
Disease,T cell receptor complex,0.5166666666666666
Disease,static agent disposition,0.5790322580645162
Disease,viral disease epidemic,0.6913793103448276
Disease,incubation end temporal region,0.5581081081081081
Disease,reverse zoonotic disposition,0.5642857142857143
Disease,COVID-19 disease course,0.6833333333333332
Disease,viricidal disposition,0.5928571428571429
Disease,viral disease,0.8
Disease,disease,0.95
Disease,opportunistic infectious disposition,0.5430232558139535
Disease,site of infection,0.575
Disease,positive-sense single-stranded RNA virus,0.5563829787234043
Disease,collective disposition,0.5879310344827586
Disease,source of infection role,0.5467741935483871
Disease,hospital-acquired infection,0.5382352941176471
Disease,primary infection,0.575
Disease,acute infection,0.5409090909090909
Disease,COVID-19 disease incidence proportion,0.609090909090909
Disease,infection incidence,0.5653846153846154
Disease,coronavirus disease,0.7192307692307692
Disease,viral adhesion disposition,0.5712121212121213
Disease,virus disorder,0.6404761904761905
Disease,pathogenic disposition,0.5879310344827586
Disease,virus aggregate,0.6772727272727272
Disease,virus generative stage,0.656896551724138
Disease,infectious disease incidence rate,0.625
Disease,community-acquired infection,0.5357142857142857
Disease,adhesion disposition,0.5981481481481481
Disease,infection start temporal region,0.581578947368421
Disease,infectious disposition,0.5879310344827586
Disease,virus replication,0.6166666666666667
Disease,chronic infection,0.5333333333333333
Disease,zoonotic disposition,0.5981481481481481
Disease,bactericidal disposition,0.5790322580645162
Disease,disorder,0.7166666666666667
Disease,acute respiratory distress syndrome,0.5928571428571429
Disease,infectious disease prevalence,0.6444444444444444
Disease,lower respiratory tract disease,0.6342105263157894
Disease,primary infection role,0.553448275862069
Disease,acute infectious disease course,0.6342105263157894
Disease,infectious disease control strategy,0.6166666666666667
Disease,communicability end process boundary,0.5197674418604651
Disease,collective resistance disposition,0.55
Disease,subclinical SARS-CoV-2 infection,0.5782051282051281
Disease,disease course,0.7833333333333333
Disease,communicability end temporal region,0.5452380952380953
Disease,simple infection,0.5804347826086956
Disease,infection end temporal region,0.5611111111111111
Disease,infectious disease incidence,0.65
Disease,infectious disease pandemic,0.6558823529411765
Disease,disease transmission model,0.6621212121212122
Disease,virus attachment stage,0.6224137931034482
Disease,process of establishing an infection,0.5662790697674418
Disease,infection incidence proportion profile,0.5166666666666666
Disease,incubation end process boundary,0.5289473684210526
Disease,infection incidence profile,0.5382352941176471
Disease,respiratory system disease,0.6621212121212122
Disease,respiratory droplet virus fomite,0.5525641025641026
Disease,latency end process boundary,0.5357142857142857
Disease,infection prevalence,0.5981481481481481
Disease,infectious disorder,0.6038461538461539
Disease,systematic infection,0.5981481481481481
Disease,infectious disease incidence proportion,0.6021739130434782
Disease,double-stranded DNA virus,0.60625
Disease,B cell receptor complex,0.5166666666666666
Disease,secondary infection role,0.5790322580645162
Disease,enterotoxin disposition,0.5833333333333334
Disease,chronic infectious disease course,0.625
Disease,virus uncoating stage,0.6285714285714286
Disease,infectious disease lifetime prevalence,0.6055555555555556
Disease,appearance of disorder,0.5879310344827586
Disease,toxin disposition,0.6166666666666667
Disease,secondary infection,0.6038461538461539
Disease,virus penetration stage,0.65
Disease,infection start process boundary,0.5525641025641026
Disease,transmissibility disposition,0.5642857142857143
Disease,virus host,0.6264705882352941
Disease,virulence factor disposition,0.5642857142857143
Disease,latency end temporal region,0.5676470588235294
Disease,invasion disposition,0.5981481481481481
Disease,infection incidence rate,0.5790322580645162
Disease,virus,0.6166666666666667
Disease,subclinical virus infection,0.5676470588235294
Disease,extracellular infection,0.55
Disease,subclinical coronavirus infection,0.55
Disease,parasitostatic disposition,0.5712121212121213
Disease,metastatic infection,0.5981481481481481
Disease,infection incidence proportion,0.5310810810810811
Disease,cytotoxin disposition,0.5928571428571429
Disease,long-term non-progressing infectious disease course,0.5706896551724138
Disease,fungicidal disposition,0.5879310344827586
Disease,coronavirus disorder,0.5981481481481481
Disease,bacteriostatic disposition,0.5712121212121213
Disease,virus transcription stage,0.60625
Infectious disease,primary infectious disposition,0.7625
Infectious disease,infectious pathogen transmissibility,0.7092592592592593
Infectious disease,passive immunity to infectious agent,0.6907407407407408
Infectious disease,process of establishing viral infection,0.6078947368421053
Infectious disease,virus adhesion susceptible cell,0.6336734693877552
Infectious disease,single-stranded DNA virus,0.636046511627907
Infectious disease,SARS-CoV-2 disorder,0.6391891891891892
Infectious disease,virus release stage,0.6662162162162162
Infectious disease,humoral immunity to infectious agent,0.6907407407407408
Infectious disease,virus translation stage,0.6695121951219513
Infectious disease,subclinical infection,0.6551282051282051
Infectious disease,double-stranded RNA virus,0.6127906976744186
Infectious disease,collective pathogenic disposition,0.6460784313725491
Infectious disease,infectious disease endemicity,0.8329787234042553
Infectious disease,infection,0.7462962962962962
Infectious disease,establishment of localization in virus host,0.630327868852459
Infectious disease,negative-sense single-stranded RNA virus,0.6396551724137931
Infectious disease,susceptibility to infectious agent,0.7
Infectious disease,infectious disease course,0.8686046511627907
Infectious disease,sterilizing immunity to infectious agent,0.6741379310344828
Infectious disease,infectious disease mortality rate,0.8029411764705883
Infectious disease,virostatic disposition,0.65
Infectious disease,SARS-COV-2 adhesion disposition,0.6132653061224489
Infectious disease,exotoxin disposition,0.6605263157894737
Infectious disease,virus synthesis stage,0.6807692307692308
Infectious disease,invasive disposition,0.6605263157894737
Infectious disease,disposition,0.5879310344827586
Infectious disease,viral disease pandemic,0.675
Infectious disease,establishment of a clinically abnormal colony,0.5611111111111111
Infectious disease,nursing-home acquired infection,0.6132653061224489
Infectious disease,local infection,0.6924242424242425
Infectious disease,fungistatic disposition,0.6451219512195122
Infectious disease,asymptomatic infectious structure carrier,0.7042372881355932
Infectious disease,infectious agent colony,0.7670731707317073
Infectious disease,disease surveillance objective specification,0.6112903225806451
Infectious disease,drug susceptibility of infectious agent,0.6780701754385965
Infectious disease,infectious structure aggregate,0.7625
Infectious disease,infected population,0.6932432432432433
Infectious disease,cidal agent disposition,0.6451219512195122
Infectious disease,COVID-19 epidemic,0.5928571428571429
Infectious disease,complex infection,0.6785714285714286
Infectious disease,immunosuppressive disposition,0.6627659574468084
Infectious disease,endotoxin disposition,0.6551282051282051
Infectious disease,source of infection site,0.7119047619047619
Infectious disease,infectious disease sporadicity,0.825
Infectious disease,coronavirus disease course,0.7227272727272727
Infectious disease,disordered virus,0.5970588235294118
Infectious disease,infectious disease control objective specification,0.7147058823529412
Infectious disease,viral disease course,0.6868421052631578
Infectious disease,infectious disease epidemic,0.85
Infectious disease,parasiticidal disposition,0.636046511627907
Infectious disease,COVID-19 pandemic,0.5928571428571429
Infectious disease,neurotoxin disposition,0.675
Infectious disease,infectious disease,0.95
Infectious disease,intracellular infection,0.6451219512195122
Infectious disease,infection incidence rate profile,0.71
Infectious disease,source of infection,0.6662162162162162
Infectious disease,infectious structure host,0.7755813953488372
Infectious disease,T cell receptor complex,0.5963414634146341
Infectious disease,static agent disposition,0.6404761904761905
Infectious disease,viral disease epidemic,0.675
Infectious disease,incubation end temporal region,0.6791666666666666
Infectious disease,reverse zoonotic disposition,0.6239130434782608
Infectious disease,COVID-19 disease course,0.6939024390243902
Infectious disease,symptomatic infectious agent carrier,0.7092592592592593
Infectious disease,viricidal disposition,0.6551282051282051
Infectious disease,viral disease,0.7403225806451613
Infectious disease,disease,0.73
Infectious disease,opportunistic infectious disposition,0.7277777777777777
Infectious disease,passive immunization against infectious agent,0.6563492063492063
Infectious disease,site of infection,0.6785714285714286
Infectious disease,positive-sense single-stranded RNA virus,0.6224137931034482
Infectious disease,collective disposition,0.675
Infectious disease,source of infection role,0.6880952380952381
Infectious disease,hospital-acquired infection,0.6277777777777778
Infectious disease,primary infection,0.6785714285714286
Infectious disease,acute infection,0.6924242424242425
Infectious disease,COVID-19 disease incidence proportion,0.6318181818181818
Infectious disease,infection incidence,0.7743243243243243
Infectious disease,herd immunity to infectious organism,0.6907407407407408
Infectious disease,coronavirus disease,0.7743243243243243
Infectious disease,viral adhesion disposition,0.6545454545454545
Infectious disease,innate immunity to infectious agent,0.6952830188679244
Infectious disease,virus disorder,0.7
Infectious disease,pathogenic disposition,0.625
Infectious disease,virus aggregate,0.6621212121212122
Infectious disease,virus generative stage,0.675
Infectious disease,infectious disease incidence rate,0.8029411764705883
Infectious disease,community-acquired infection,0.6239130434782608
Infectious disease,adhesion disposition,0.6605263157894737
Infectious disease,infection start temporal region,0.7153061224489795
Infectious disease,infectious disposition,0.825
Infectious disease,virus replication,0.6214285714285714
Infectious disease,chronic infection,0.6785714285714286
Infectious disease,zoonotic disposition,0.6605263157894737
Infectious disease,bactericidal disposition,0.6404761904761905
Infectious disease,disorder,0.6038461538461539
Infectious disease,acute respiratory distress syndrome,0.6575471698113208
Infectious disease,infectious disease prevalence,0.8329787234042553
Infectious disease,lower respiratory tract disease,0.6744897959183673
Infectious disease,primary infection role,0.7
Infectious disease,acute infectious disease course,0.8173469387755102
Infectious disease,infectious disease control strategy,0.789622641509434
Infectious disease,immunization against infectious agent,0.6863636363636364
Infectious disease,communicability end process boundary,0.5981481481481481
Infectious disease,infectious agent population,0.7388888888888888
Infectious disease,infectious structure,0.7921052631578948
Infectious disease,infectious structure host role,0.7625
Infectious disease,collective resistance disposition,0.6460784313725491
Infectious disease,subclinical SARS-CoV-2 infection,0.61
Infectious disease,disease course,0.66875
Infectious disease,communicability end temporal region,0.6009433962264151
Infectious disease,simple infection,0.6852941176470588
Infectious disease,infection end temporal region,0.7265957446808511
Infectious disease,infectious disease incidence,0.8413043478260869
Infectious disease,infectious disease pandemic,0.85
Infectious disease,disease transmission model,0.6318181818181818
Infectious disease,virus attachment stage,0.625
Infectious disease,process of establishing an infection,0.5981481481481481
Infectious disease,infection incidence proportion profile,0.6642857142857143
Infectious disease,incubation end process boundary,0.6540816326530612
Infectious disease,infection incidence profile,0.7166666666666667
Infectious disease,respiratory system disease,0.7227272727272727
Infectious disease,respiratory droplet virus fomite,0.63
Infectious disease,infectious structure generative stage,0.740909090909091
Infectious disease,infectious agent reservoir,0.7681818181818181
Infectious disease,latency end process boundary,0.6021739130434782
Infectious disease,asymptomatic infectious agent carrier,0.7045454545454546
Infectious disease,infectious agent,0.8323529411764706
Infectious disease,infection prevalence,0.7657894736842106
Infectious disease,infectious disorder,0.8554054054054054
Infectious disease,systematic infection,0.6605263157894737
Infectious disease,infectious disease incidence proportion,0.7657894736842106
Infectious disease,double-stranded DNA virus,0.6127906976744186
Infectious disease,symptomatic infectious structure carrier,0.7086206896551723
Infectious disease,B cell receptor complex,0.5963414634146341
Infectious disease,secondary infection role,0.6880952380952381
Infectious disease,enterotoxin disposition,0.6695121951219513
Infectious disease,leukocyte-mediated immunity to infectious agent,0.65
Infectious disease,active immunization against infectious agent,0.6596774193548387
Infectious disease,chronic infectious disease course,0.8029411764705883
Infectious disease,infectious human pathogen,0.7523255813953489
Infectious disease,virus uncoating stage,0.6807692307692308
Infectious disease,infectious disease lifetime prevalence,0.7714285714285714
Infectious disease,appearance of disorder,0.65
Infectious disease,toxin disposition,0.65
Infectious disease,secondary infection,0.6662162162162162
Infectious disease,virus penetration stage,0.6939024390243902
Infectious disease,infection start process boundary,0.69
Infectious disease,vaccination against infectious agent,0.6907407407407408
Infectious disease,transmissibility disposition,0.6239130434782608
Infectious disease,infectious agent host,0.7833333333333333
Infectious disease,acquired immunity to infectious agent,0.6863636363636364
Infectious disease,virus host,0.6285714285714286
Infectious disease,virulence factor disposition,0.6891304347826087
Infectious disease,infectious agent host role,0.7681818181818181
Infectious disease,latency end temporal region,0.6055555555555556
Infectious disease,invasion disposition,0.6868421052631578
Infectious disease,infection incidence rate,0.7595238095238095
Infectious disease,virus,0.5804347826086956
Infectious disease,subclinical virus infection,0.65
Infectious disease,extracellular infection,0.6451219512195122
Infectious disease,subclinical coronavirus infection,0.6264705882352941
Infectious disease,parasitostatic disposition,0.6545454545454545
Infectious disease,diseased population,0.6391891891891892
Infectious disease,metastatic infection,0.6605263157894737
Infectious disease,infection incidence proportion,0.7
Infectious disease,infectious agent generative stage,0.7441176470588234
Infectious disease,cytotoxin disposition,0.6551282051282051
Infectious disease,long-term non-progressing infectious disease course,0.7108695652173913
Infectious disease,fungicidal disposition,0.65
Infectious disease,coronavirus disorder,0.6868421052631578
Infectious disease,bacteriostatic disposition,0.6772727272727272
Infectious disease,virus transcription stage,0.6825581395348838
Coronavirus infection,primary infectious disposition,0.7049019607843137
Coronavirus infection,process of establishing viral infection,0.7166666666666667
Coronavirus infection,virus adhesion susceptible cell,0.6615384615384616
Coronavirus infection,single-stranded DNA virus,0.6239130434782608
Coronavirus infection,SARS-CoV-2 disorder,0.6
Coronavirus infection,virus release stage,0.65
Coronavirus infection,virus translation stage,0.7
Coronavirus infection,subclinical infection,0.7595238095238095
Coronavirus infection,double-stranded RNA virus,0.6456521739130434
Coronavirus infection,collective pathogenic disposition,0.6537037037037037
Coronavirus infection,infectious disease endemicity,0.65
Coronavirus infection,infection,0.75
Coronavirus infection,establishment of localization in virus host,0.60625
Coronavirus infection,negative-sense single-stranded RNA virus,0.6139344262295081
Coronavirus infection,infectious disease course,0.6456521739130434
Coronavirus infection,communicability start process boundary,0.6194915254237288
Coronavirus infection,infectious disease mortality rate,0.6166666666666667
Coronavirus infection,virostatic disposition,0.6825581395348838
Coronavirus infection,SARS-COV-2 adhesion disposition,0.6615384615384616
Coronavirus infection,exotoxin disposition,0.6939024390243902
Coronavirus infection,virus synthesis stage,0.6642857142857143
Coronavirus infection,invasive disposition,0.6939024390243902
Coronavirus infection,disposition,0.66875
Coronavirus infection,viral disease pandemic,0.636046511627907
Coronavirus infection,establishment of a clinically abnormal colony,0.5863636363636363
Coronavirus infection,nursing-home acquired infection,0.7384615384615384
Coronavirus infection,local infection,0.7833333333333333
Coronavirus infection,fungistatic disposition,0.6545454545454545
Coronavirus infection,disease surveillance objective specification,0.6192307692307693
Coronavirus infection,cidal agent disposition,0.6545454545454545
Coronavirus infection,COVID-19 epidemic,0.6605263157894737
Coronavirus infection,complex infection,0.7657894736842106
Coronavirus infection,immunosuppressive disposition,0.65
Coronavirus infection,endotoxin disposition,0.6880952380952381
Coronavirus infection,source of infection site,0.7388888888888888
Coronavirus infection,infectious disease sporadicity,0.6264705882352941
Coronavirus infection,coronavirus disease course,0.7904255319148936
Coronavirus infection,disordered virus,0.6391891891891892
Coronavirus infection,infectious disease control objective specification,0.6330985915492958
Coronavirus infection,viral disease course,0.6451219512195122
Coronavirus infection,infectious disease epidemic,0.6166666666666667
Coronavirus infection,parasiticidal disposition,0.6456521739130434
Coronavirus infection,neurotoxin disposition,0.6825581395348838
Coronavirus infection,infectious disease,0.6551282051282051
Coronavirus infection,intracellular infection,0.7454545454545455
Coronavirus infection,infection incidence rate profile,0.6386792452830189
Coronavirus infection,source of infection,0.775
Coronavirus infection,T cell receptor complex,0.609090909090909
Coronavirus infection,static agent disposition,0.65
Coronavirus infection,viral disease epidemic,0.636046511627907
Coronavirus infection,contagiousness,0.7071428571428571
Coronavirus infection,incubation end temporal region,0.6264705882352941
Coronavirus infection,reverse zoonotic disposition,0.6744897959183673
Coronavirus infection,coronavirus pathogenesis,0.7833333333333333
Coronavirus infection,COVID-19 disease course,0.6545454545454545
Coronavirus infection,viricidal disposition,0.6642857142857143
Coronavirus infection,viral disease,0.6264705882352941
Coronavirus infection,communicability start temporal region,0.6396551724137931
Coronavirus infection,disease,0.5571428571428572
Coronavirus infection,communicability interval,0.65
Coronavirus infection,opportunistic infectious disposition,0.7131578947368421
Coronavirus infection,site of infection,0.7394736842105263
Coronavirus infection,positive-sense single-stranded RNA virus,0.5975409836065574
Coronavirus infection,collective disposition,0.6825581395348838
Coronavirus infection,source of infection role,0.7388888888888888
Coronavirus infection,hospital-acquired infection,0.7416666666666667
Coronavirus infection,primary infection,0.7921052631578948
Coronavirus infection,acute infection,0.7833333333333333
Coronavirus infection,COVID-19 disease incidence proportion,0.6913793103448276
Coronavirus infection,infection incidence,0.675
Coronavirus infection,coronavirus disease,0.8
Coronavirus infection,coronavirus,0.79375
Coronavirus infection,viral adhesion disposition,0.6627659574468084
Coronavirus infection,coronavirus aggregate,0.7833333333333333
Coronavirus infection,virus disorder,0.6785714285714286
Coronavirus infection,pathogenic disposition,0.6593023255813953
Coronavirus infection,virus aggregate,0.6722222222222223
Coronavirus infection,virus generative stage,0.6825581395348838
Coronavirus infection,infectious disease incidence rate,0.6351851851851852
Coronavirus infection,community-acquired infection,0.7765306122448979
Coronavirus infection,adhesion disposition,0.6695121951219513
Coronavirus infection,infection start temporal region,0.6423076923076922
Coronavirus infection,infectious disposition,0.6825581395348838
Coronavirus infection,virus replication,0.7657894736842106
Coronavirus infection,chronic infection,0.8447368421052631
Coronavirus infection,zoonotic disposition,0.6939024390243902
Coronavirus infection,bactericidal disposition,0.6722222222222223
Coronavirus infection,disorder,0.553448275862069
Coronavirus infection,acute respiratory distress syndrome,0.6107142857142857
Coronavirus infection,infectious disease prevalence,0.63
Coronavirus infection,lower respiratory tract disease,0.6038461538461539
Coronavirus infection,primary infection role,0.7523255813953489
Coronavirus infection,acute infectious disease course,0.6615384615384616
Coronavirus infection,infectious disease control strategy,0.6285714285714286
Coronavirus infection,communicability end process boundary,0.6254385964912281
Coronavirus infection,collective resistance disposition,0.6722222222222223
Coronavirus infection,coronavirus replication,0.859090909090909
Coronavirus infection,subclinical SARS-CoV-2 infection,0.7330188679245283
Coronavirus infection,disease course,0.5928571428571429
Coronavirus infection,communicability end temporal region,0.6464285714285714
Coronavirus infection,respiratory droplet coronavirus fomite,0.6872881355932203
Coronavirus infection,simple infection,0.7472972972972972
Coronavirus infection,infection end temporal region,0.63
Coronavirus infection,infectious disease incidence,0.6540816326530612
Coronavirus infection,infectious disease pandemic,0.6375
Coronavirus infection,disease transmission model,0.598936170212766
Coronavirus infection,virus attachment stage,0.636046511627907
Coronavirus infection,process of establishing an infection,0.7131578947368421
Coronavirus infection,infection incidence proportion profile,0.6533898305084747
Coronavirus infection,incubation end process boundary,0.6038461538461539
Coronavirus infection,infection incidence profile,0.6375
Coronavirus infection,respiratory system disease,0.598936170212766
Coronavirus infection,respiratory droplet virus fomite,0.6575471698113208
Coronavirus infection,latency end process boundary,0.5928571428571429
Coronavirus infection,communicability,0.6444444444444444
Coronavirus infection,infection prevalence,0.6695121951219513
Coronavirus infection,infectious disorder,0.65
Coronavirus infection,systematic infection,0.7426829268292683
Coronavirus infection,infectious disease incidence proportion,0.6666666666666667
Coronavirus infection,double-stranded DNA virus,0.6456521739130434
Coronavirus infection,B cell receptor complex,0.609090909090909
Coronavirus infection,secondary infection role,0.7833333333333333
Coronavirus infection,enterotoxin disposition,0.6772727272727272
Coronavirus infection,chronic infectious disease course,0.7092592592592593
Coronavirus infection,virus uncoating stage,0.7119047619047619
Coronavirus infection,infectious disease lifetime prevalence,0.6364406779661017
Coronavirus infection,appearance of disorder,0.5895348837209302
Coronavirus infection,toxin disposition,0.6868421052631578
Coronavirus infection,secondary infection,0.825
Coronavirus infection,virus penetration stage,0.7227272727272727
Coronavirus infection,infection start process boundary,0.619811320754717
Coronavirus infection,transmissibility disposition,0.6540816326530612
Coronavirus infection,virus host,0.6758064516129032
Coronavirus infection,virulence factor disposition,0.6744897959183673
Coronavirus infection,latency end temporal region,0.6375
Coronavirus infection,invasion disposition,0.6695121951219513
Coronavirus infection,infection incidence rate,0.65
Coronavirus infection,virus,0.6423076923076922
Coronavirus infection,subclinical virus infection,0.825
Coronavirus infection,extracellular infection,0.7454545454545455
Coronavirus infection,action specification,0.7182926829268292
Coronavirus infection,subclinical coronavirus infection,0.8388888888888889
Coronavirus infection,parasitostatic disposition,0.6627659574468084
Coronavirus infection,metastatic infection,0.7426829268292683
Coronavirus infection,infection incidence proportion,0.6852941176470588
Coronavirus infection,cytotoxin disposition,0.7119047619047619
Coronavirus infection,long-term non-progressing infectious disease course,0.6583333333333334
Coronavirus infection,fungicidal disposition,0.6593023255813953
Coronavirus infection,coronavirus disorder,0.7914634146341464
Coronavirus infection,bacteriostatic disposition,0.6840425531914894
Coronavirus infection,virus transcription stage,0.7108695652173913
Close contact,infectious disease course,0.6342105263157894
Close contact,establishment of a clinically abnormal colony,0.5879310344827586
Close contact,pathogen portal of entry site,0.6166666666666667
Close contact,coronavirus disease course,0.6294871794871795
Close contact,viral disease course,0.6318181818181818
Close contact,T cell receptor complex,0.6166666666666667
Close contact,incubation end temporal region,0.5895348837209302
Close contact,COVID-19 disease course,0.6444444444444444
Close contact,entry into host,0.6285714285714286
Close contact,entry into host through host barriers,0.57
Close contact,pathogen portal of entry role,0.6166666666666667
Close contact,polymerase chain reaction,0.6868421052631578
Close contact,contact pathogen transmission process,0.61
Close contact,pathogen portal of entry,0.6391891891891892
Close contact,acute infectious disease course,0.609090909090909
Close contact,communicability end process boundary,0.6132653061224489
Close contact,disease course,0.6351851851851852
Close contact,communicability end temporal region,0.575
Close contact,infection end temporal region,0.5928571428571429
Close contact,incubation end process boundary,0.6318181818181818
Close contact,respiratory system disease,0.5782051282051281
Close contact,latency end process boundary,0.6207317073170732
Close contact,systematic infection,0.6318181818181818
Close contact,B cell receptor complex,0.6166666666666667
Close contact,chronic infectious disease course,0.6021739130434782
Close contact,latency end temporal region,0.6
Close contact,action specification,0.6621212121212122
Close contact,contact tracing,0.7
Close contact,long-term non-progressing infectious disease course,0.590625
Moderate COVID-19,case isolation control strategy,0.575
Moderate COVID-19,COVID-19 mortality rate,0.65
Moderate COVID-19,infectious disease mortality rate,0.61
Moderate COVID-19,quarantine control strategy,0.609090909090909
Moderate COVID-19,COVID-19 prevalence,0.6722222222222223
Moderate COVID-19,establishment of a clinically abnormal colony,0.5629032258064516
Moderate COVID-19,intermediate host,0.6558823529411765
Moderate COVID-19,adhesion factor,0.60625
Moderate COVID-19,COVID-19 incidence rate,0.65
Moderate COVID-19,COVID-19 epidemic,0.6852941176470588
Moderate COVID-19,COVID-19 sporadicity,0.6662162162162162
Moderate COVID-19,COVID-19,0.77
Moderate COVID-19,infectious disease control objective specification,0.5992537313432835
Moderate COVID-19,object aggregate,0.6318181818181818
Moderate COVID-19,object,0.5804347826086956
Moderate COVID-19,COVID-19 pandemic,0.6852941176470588
Moderate COVID-19,infection incidence rate profile,0.6540816326530612
Moderate COVID-19,T cell receptor complex,0.6
Moderate COVID-19,incubation end temporal region,0.598936170212766
Moderate COVID-19,invasion factor,0.575
Moderate COVID-19,COVID-19 disease course,0.65
Moderate COVID-19,COVID-19 disease incidence proportion,0.6166666666666667
Moderate COVID-19,COVID-19 lifetime prevalence,0.6277777777777778
Moderate COVID-19,COVID-19 incidence,0.6785714285714286
Moderate COVID-19,infectious disease incidence rate,0.63
Moderate COVID-19,infectious disease control strategy,0.6038461538461539
Moderate COVID-19,communicability end process boundary,0.6009433962264151
Moderate COVID-19,COVID-19 endemicity,0.6722222222222223
Moderate COVID-19,communicability end temporal region,0.5846153846153846
Moderate COVID-19,infection end temporal region,0.6021739130434782
Moderate COVID-19,incubation end process boundary,0.5958333333333333
Moderate COVID-19,vector control strategy,0.575
Moderate COVID-19,latency end process boundary,0.6055555555555556
Moderate COVID-19,SARS-CoV-2 incidence rate,0.6166666666666667
Moderate COVID-19,intermediate host role,0.6294871794871795
Moderate COVID-19,place closure control strategy,0.5776595744680851
Moderate COVID-19,B cell receptor complex,0.6
Moderate COVID-19,virulence factor disposition,0.5833333333333334
Moderate COVID-19,latency end temporal region,0.5863636363636363
Moderate COVID-19,infection incidence rate,0.6207317073170732
Moderate COVID-19,virulence factor,0.6015151515151516
Status,virus release stage,0.57
Status,virus translation stage,0.6224137931034482
Status,virus synthesis stage,0.5611111111111111
Status,establishment of a clinically abnormal colony,0.5284313725490196
Status,T cell receptor complex,0.5189655172413793
Status,SARS-CoV-2 attachment stage,0.6015151515151516
Status,SARS-CoV-2 uncoating stage,0.575
Status,SARS-CoV-2 transcription stage,0.5888888888888889
Status,generative stage,0.5863636363636363
Status,pathogen generative stage,0.5790322580645162
Status,virus generative stage,0.5928571428571429
Status,lower respiratory tract disease,0.5851351351351352
Status,SARS-CoV-2 release stage,0.55
Status,SARS-CoV-2 synthesis stage,0.575
Status,virus attachment stage,0.6285714285714286
Status,infectious structure generative stage,0.5662790697674418
Status,place closure control strategy,0.5611111111111111
Status,quality,0.6038461538461539
Status,SARS-CoV-2 penetration stage,0.5970588235294118
Status,virus uncoating stage,0.5981481481481481
Status,virus penetration stage,0.6224137931034482
Status,action specification,0.5653846153846154
Status,SARS-CoV-2 genome replication stage,0.5475609756097561
Status,infectious agent generative stage,0.5782051282051281
Status,virus transcription stage,0.6112903225806451
COVID-19 dedicated facility,virus adhesion susceptible cell,0.656896551724138
COVID-19 dedicated facility,cell space,0.5851351351351352
COVID-19 dedicated facility,COVID-19 mortality rate,0.75
COVID-19 dedicated facility,infectious disease mortality rate,0.6666666666666667
COVID-19 dedicated facility,COVID-19 prevalence,0.7326086956521739
COVID-19 dedicated facility,establishment of a clinically abnormal colony,0.5888888888888889
COVID-19 dedicated facility,hospital facility,0.7227272727272727
COVID-19 dedicated facility,material processing,0.5804347826086956
COVID-19 dedicated facility,COVID-19 incidence rate,0.77
COVID-19 dedicated facility,COVID-19 epidemic,0.7454545454545455
COVID-19 dedicated facility,source of infection site,0.6264705882352941
COVID-19 dedicated facility,COVID-19 sporadicity,0.7691489361702127
COVID-19 dedicated facility,COVID-19,0.6785714285714286
COVID-19 dedicated facility,facility,0.6785714285714286
COVID-19 dedicated facility,COVID-19 pandemic,0.7454545454545455
COVID-19 dedicated facility,infection incidence rate profile,0.6703389830508475
COVID-19 dedicated facility,source of infection,0.6021739130434782
COVID-19 dedicated facility,T cell receptor complex,0.61
COVID-19 dedicated facility,incubation end temporal region,0.6254385964912281
COVID-19 dedicated facility,COVID-19 disease course,0.75
COVID-19 dedicated facility,source of infection role,0.6068627450980393
COVID-19 dedicated facility,COVID-19 disease incidence proportion,0.715625
COVID-19 dedicated facility,COVID-19 lifetime prevalence,0.7227272727272727
COVID-19 dedicated facility,SARS-COV-2 adhesion susceptible cell,0.6722222222222223
COVID-19 dedicated facility,COVID-19 incidence,0.7388888888888888
COVID-19 dedicated facility,processed material,0.6277777777777778
COVID-19 dedicated facility,infectious disease incidence rate,0.6333333333333333
COVID-19 dedicated facility,material entity,0.6404761904761905
COVID-19 dedicated facility,communicability end process boundary,0.6246031746031746
COVID-19 dedicated facility,COVID-19 endemicity,0.7978260869565217
COVID-19 dedicated facility,communicability end temporal region,0.6435483870967742
COVID-19 dedicated facility,infection end temporal region,0.6285714285714286
COVID-19 dedicated facility,incubation end process boundary,0.6224137931034482
COVID-19 dedicated facility,latency end process boundary,0.6136363636363636
COVID-19 dedicated facility,SARS-CoV-2 incidence rate,0.6807692307692308
COVID-19 dedicated facility,quality,0.5970588235294118
COVID-19 dedicated facility,B cell receptor complex,0.61
COVID-19 dedicated facility,active immunization against infectious agent,0.6049295774647887
COVID-19 dedicated facility,healthcare facility,0.7326086956521739
COVID-19 dedicated facility,latency end temporal region,0.6166666666666667
COVID-19 dedicated facility,infection incidence rate,0.6460784313725491
COVID-19 dedicated facility,cell,0.5467741935483871
District,infectious disease course,0.5712121212121213
District,establishment of a clinically abnormal colony,0.5443396226415094
District,local infection,0.5804347826086956
District,infectious agent colony,0.5790322580645162
District,coronavirus disease course,0.5676470588235294
District,spatial region,0.6318181818181818
District,viral disease course,0.5928571428571429
District,T cell receptor complex,0.5790322580645162
District,incubation end temporal region,0.5552631578947369
District,temporal region,0.5804347826086956
District,COVID-19 disease course,0.5790322580645162
District,communicability start temporal region,0.5611111111111111
District,one-dimensional temporal region,0.6038461538461539
District,three-dimensional spatial region,0.6
District,zero-dimensional temporal region,0.6
District,normal resident microbiota population,0.5611111111111111
District,colony,0.5214285714285714
District,infection start temporal region,0.5782051282051281
District,geospatial region,0.61
District,lower respiratory tract disease,0.5782051282051281
District,acute infectious disease course,0.5525641025641026
District,disease course,0.6318181818181818
District,zero-dimensional spatial region,0.6038461538461539
District,communicability end temporal region,0.5430232558139535
District,infection end temporal region,0.5581081081081081
District,pathogen birth temporal region,0.5552631578947369
District,B cell receptor complex,0.5467741935483871
District,geographical region,0.5611111111111111
District,chronic infectious disease course,0.5475609756097561
District,spatiotemporal region,0.5879310344827586
District,two-dimensional spatial region,0.6078947368421053
District,pathogen death temporal region,0.5552631578947369
District,latency end temporal region,0.5642857142857143
District,one-dimensional spatial region,0.6078947368421053
District,long-term non-progressing infectious disease course,0.5347457627118644
InfectedNephew,infected population,0.7227272727272727
InfectedNephew,T cell receptor complex,0.5851351351351352
Patient,passive immunity to infectious agent,0.6127906976744186
Patient,case isolation control strategy,0.581578947368421
Patient,COVID-19 mortality rate,0.55
Patient,infectious disease mortality rate,0.55
Patient,establishment of a clinically abnormal colony,0.5461538461538461
Patient,COVID-19 incidence rate,0.5833333333333334
Patient,infection incidence rate profile,0.5782051282051281
Patient,T cell receptor complex,0.55
Patient,incubation end temporal region,0.6121621621621621
Patient,ribonucleic acid,0.5369565217391304
Patient,passive immunization against infectious agent,0.5846153846153846
Patient,deoxyribonucleic acid,0.5214285714285714
Patient,generically dependent continuant,0.5782051282051281
Patient,infectious disease incidence rate,0.575
Patient,lower respiratory tract disease,0.581578947368421
Patient,communicability end process boundary,0.5430232558139535
Patient,communicability end temporal region,0.569047619047619
Patient,infection end temporal region,0.5888888888888889
Patient,incubation end process boundary,0.581578947368421
Patient,latency end process boundary,0.5642857142857143
Patient,SARS-CoV-2 incidence rate,0.60625
Patient,B cell receptor complex,0.55
Patient,specifically dependent continuant,0.6
Patient,nucleic acid,0.5552631578947369
Patient,latency end temporal region,0.5970588235294118
Patient,infection incidence rate,0.6112903225806451
Medical clinic,COVID-19 mortality rate,0.5581081081081081
Medical clinic,establishment of localization in virus host,0.6078947368421053
Medical clinic,infectious disease mortality rate,0.598936170212766
Medical clinic,establishment of a clinically abnormal colony,0.6194915254237288
Medical clinic,hospital facility,0.6758064516129032
Medical clinic,establishment of localization,0.636046511627907
Medical clinic,COVID-19 incidence rate,0.6121621621621621
Medical clinic,negative regulation of establishment of localization,0.5863636363636363
Medical clinic,infection incidence rate profile,0.6021739130434782
Medical clinic,T cell receptor complex,0.5851351351351352
Medical clinic,infectious disease incidence rate,0.6414893617021277
Medical clinic,establishment of localization in host,0.6264705882352941
Medical clinic,pathologic immunosuppression,0.5928571428571429
Medical clinic,respiratory system disease,0.575
Medical clinic,SARS-CoV-2 incidence rate,0.6038461538461539
Medical clinic,B cell receptor complex,0.5851351351351352
Medical clinic,establishment of localization in human host,0.6078947368421053
Medical clinic,infection incidence rate,0.6342105263157894
Symptom,primary infectious disposition,0.5581081081081081
Symptom,collective pathogenic disposition,0.55
Symptom,virostatic disposition,0.5879310344827586
Symptom,SARS-COV-2 adhesion disposition,0.5552631578947369
Symptom,exotoxin disposition,0.5981481481481481
Symptom,invasive disposition,0.5981481481481481
Symptom,disposition,0.6722222222222223
Symptom,establishment of a clinically abnormal colony,0.5461538461538461
Symptom,fungistatic disposition,0.5833333333333334
Symptom,cidal agent disposition,0.5833333333333334
Symptom,complex infection,0.6166666666666667
Symptom,immunosuppressive disposition,0.5611111111111111
Symptom,endotoxin disposition,0.5928571428571429
Symptom,parasiticidal disposition,0.575
Symptom,neurotoxin disposition,0.5879310344827586
Symptom,T cell receptor complex,0.5833333333333334
Symptom,static agent disposition,0.5790322580645162
Symptom,immunoglobulin complex,0.553448275862069
Symptom,incubation end temporal region,0.5310810810810811
Symptom,reverse zoonotic disposition,0.5642857142857143
Symptom,viricidal disposition,0.5928571428571429
Symptom,opportunistic infectious disposition,0.5430232558139535
Symptom,directive information content entity,0.5197674418604651
Symptom,collective disposition,0.5879310344827586
Symptom,viral adhesion disposition,0.5712121212121213
Symptom,information content entity,0.5409090909090909
Symptom,pathogenic disposition,0.5879310344827586
Symptom,adhesion disposition,0.5981481481481481
Symptom,infectious disposition,0.5879310344827586
Symptom,zoonotic disposition,0.5981481481481481
Symptom,bactericidal disposition,0.5790322580645162
Symptom,acute respiratory distress syndrome,0.569047619047619
Symptom,communicability end process boundary,0.5197674418604651
Symptom,collective resistance disposition,0.55
Symptom,communicability end temporal region,0.5452380952380953
Symptom,infection end temporal region,0.5333333333333333
Symptom,disease transmission model,0.5712121212121213
Symptom,incubation end process boundary,0.5026315789473684
Symptom,latency end process boundary,0.5357142857142857
Symptom,quality,0.5214285714285714
Symptom,B cell receptor complex,0.5833333333333334
Symptom,enterotoxin disposition,0.5833333333333334
Symptom,macromolecular complex,0.553448275862069
Symptom,toxin disposition,0.6166666666666667
Symptom,transmissibility disposition,0.5928571428571429
Symptom,descriptive information content entity,0.5611111111111111
Symptom,virulence factor disposition,0.5642857142857143
Symptom,symptom,0.95
Symptom,designative information content entity,0.5388888888888889
Symptom,latency end temporal region,0.5676470588235294
Symptom,invasion disposition,0.5981481481481481
Symptom,parasitostatic disposition,0.5712121212121213
Symptom,cytotoxin disposition,0.5928571428571429
Symptom,fungicidal disposition,0.5879310344827586
Symptom,bacteriostatic disposition,0.5712121212121213
InfectedViaJob,establishment of a clinically abnormal colony,0.5686440677966101
InfectedViaJob,infected population,0.7530303030303032
InfectedViaJob,T cell receptor complex,0.5581081081081081
InfectedViaJob,B cell receptor complex,0.5581081081081081
Mild and very mild COVID-19,COVID-19 mortality rate,0.61
Mild and very mild COVID-19,infectious disease mortality rate,0.5833333333333334
Mild and very mild COVID-19,COVID-19 prevalence,0.6239130434782608
Mild and very mild COVID-19,establishment of a clinically abnormal colony,0.6166666666666667
Mild and very mild COVID-19,pathogen portal of entry site,0.5928571428571429
Mild and very mild COVID-19,COVID-19 incidence rate,0.61
Mild and very mild COVID-19,COVID-19 epidemic,0.6318181818181818
Mild and very mild COVID-19,source of infection site,0.5676470588235294
Mild and very mild COVID-19,COVID-19 sporadicity,0.6202127659574468
Mild and very mild COVID-19,COVID-19,0.6785714285714286
Mild and very mild COVID-19,COVID-19 pandemic,0.6772727272727272
Mild and very mild COVID-19,infection incidence rate profile,0.6025423728813559
Mild and very mild COVID-19,T cell receptor complex,0.59
Mild and very mild COVID-19,incubation end temporal region,0.6254385964912281
Mild and very mild COVID-19,COVID-19 disease course,0.61
Mild and very mild COVID-19,ribonucleic acid,0.636046511627907
Mild and very mild COVID-19,site of infection,0.5863636363636363
Mild and very mild COVID-19,deoxyribonucleic acid,0.6375
Mild and very mild COVID-19,COVID-19 disease incidence proportion,0.621875
Mild and very mild COVID-19,COVID-19 lifetime prevalence,0.5954545454545455
Mild and very mild COVID-19,COVID-19 incidence,0.6277777777777778
Mild and very mild COVID-19,infectious disease incidence rate,0.6
Mild and very mild COVID-19,site,0.5145161290322581
Mild and very mild COVID-19,epitope site,0.5525641025641026
Mild and very mild COVID-19,lower respiratory tract disease,0.5879310344827586
Mild and very mild COVID-19,communicability end process boundary,0.6246031746031746
Mild and very mild COVID-19,COVID-19 endemicity,0.6673913043478261
Mild and very mild COVID-19,communicability end temporal region,0.6435483870967742
Mild and very mild COVID-19,infection end temporal region,0.6285714285714286
Mild and very mild COVID-19,colonization of human,0.575
Mild and very mild COVID-19,incubation end process boundary,0.6224137931034482
Mild and very mild COVID-19,pathogen portal of exit site,0.5954545454545455
Mild and very mild COVID-19,latency end process boundary,0.6318181818181818
Mild and very mild COVID-19,SARS-CoV-2 incidence rate,0.5846153846153846
Mild and very mild COVID-19,B cell receptor complex,0.59
Mild and very mild COVID-19,active immunization against infectious agent,0.5767605633802817
Mild and very mild COVID-19,establishment of localization in human host,0.5785714285714285
Mild and very mild COVID-19,infectious human pathogen,0.5846153846153846
Mild and very mild COVID-19,nucleic acid,0.6294871794871795
Mild and very mild COVID-19,latency end temporal region,0.6351851851851852
Mild and very mild COVID-19,infection incidence rate,0.6068627450980393
State wise statistics,case isolation control strategy,0.6423076923076922
State wise statistics,COVID-19 mortality rate,0.5863636363636363
State wise statistics,infectious disease mortality rate,0.6351851851851852
State wise statistics,establishment of a clinically abnormal colony,0.6166666666666667
State wise statistics,organism population,0.625
State wise statistics,material processing,0.65
State wise statistics,infected population,0.6
State wise statistics,pathogen portal of entry site,0.63
State wise statistics,COVID-19 incidence rate,0.5863636363636363
State wise statistics,source of infection site,0.65
State wise statistics,infection incidence rate profile,0.6009433962264151
State wise statistics,source of infection,0.625
State wise statistics,T cell receptor complex,0.5863636363636363
State wise statistics,incubation end temporal region,0.6068627450980393
State wise statistics,site of infection,0.6605263157894737
State wise statistics,directive information content entity,0.6078947368421053
State wise statistics,source of infection role,0.6055555555555556
State wise statistics,acute infection,0.6722222222222223
State wise statistics,plan specification,0.6294871794871795
State wise statistics,information content entity,0.6202127659574468
State wise statistics,processed material,0.6294871794871795
State wise statistics,infectious disease incidence rate,0.6166666666666667
State wise statistics,normal resident microbiota population,0.6051724137931035
State wise statistics,material entity,0.6722222222222223
State wise statistics,process that results in death,0.65
State wise statistics,site,0.57
State wise statistics,epitope site,0.6621212121212122
State wise statistics,acute respiratory distress syndrome,0.6642857142857143
State wise statistics,lower respiratory tract disease,0.6423076923076922
State wise statistics,acute infectious disease course,0.6807692307692308
State wise statistics,communicability end process boundary,0.5728070175438597
State wise statistics,infectious agent population,0.6166666666666667
State wise statistics,communicability end temporal region,0.5928571428571429
State wise statistics,infection end temporal region,0.59
State wise statistics,incubation end process boundary,0.5846153846153846
State wise statistics,pathogen portal of exit site,0.6336734693877552
State wise statistics,latency end process boundary,0.6132653061224489
State wise statistics,SARS-CoV-2 incidence rate,0.6239130434782608
State wise statistics,angiotensin-converting enzyme 2,0.5846153846153846
State wise statistics,susceptible population,0.636046511627907
State wise statistics,B cell receptor complex,0.5636363636363636
State wise statistics,immune population,0.6078947368421053
State wise statistics,active immunization against infectious agent,0.65
State wise statistics,descriptive information content entity,0.6194915254237288
State wise statistics,designative information content entity,0.6364406779661017
State wise statistics,latency end temporal region,0.6375
State wise statistics,infection incidence rate,0.6055555555555556
State wise statistics,diseased population,0.65
City,infectious disease course,0.5189655172413793
City,establishment of a clinically abnormal colony,0.5112244897959184
City,local infection,0.6078947368421053
City,complex infection,0.5928571428571429
City,coronavirus disease course,0.5166666666666666
City,T cell receptor complex,0.524074074074074
City,COVID-19 disease course,0.524074074074074
City,lower respiratory tract disease,0.5357142857142857
City,acute infectious disease course,0.5357142857142857
City,division of geopolitical entity,0.5642857142857143
City,disease course,0.5055555555555555
City,place closure control strategy,0.5382352941176471
City,B cell receptor complex,0.524074074074074
City,chronic infectious disease course,0.5310810810810811
town,single-stranded RNA retrovirus,0.5088235294117647
town,double-stranded RNA virus,0.5189655172413793
town,infectious disease course,0.5189655172413793
town,infectious disease mortality rate,0.504054054054054
town,establishment of a clinically abnormal colony,0.5112244897959184
town,local infection,0.6078947368421053
town,geographical entity,0.5369565217391304
town,COVID-19 incidence rate,0.524074074074074
town,coronavirus disease course,0.5166666666666666
town,spatial region,0.6166666666666667
town,infection incidence rate profile,0.5333333333333333
town,T cell receptor complex,0.524074074074074
town,incubation end temporal region,0.5382352941176471
town,temporal region,0.6078947368421053
town,communicability start temporal region,0.523170731707317
town,one-dimensional temporal region,0.5357142857142857
town,three-dimensional spatial region,0.5333333333333333
town,zero-dimensional temporal region,0.5333333333333333
town,infectious disease incidence rate,0.5310810810810811
town,infection start temporal region,0.5357142857142857
town,geospatial region,0.5928571428571429
town,acute infectious disease course,0.5071428571428571
town,communicability end process boundary,0.525
town,division of geopolitical entity,0.5071428571428571
town,disease course,0.5055555555555555
town,zero-dimensional spatial region,0.5357142857142857
town,communicability end temporal region,0.5269230769230769
town,infection end temporal region,0.5409090909090909
town,incubation end process boundary,0.5357142857142857
town,latency end process boundary,0.54375
town,SARS-CoV-2 incidence rate,0.5189655172413793
town,pathogen birth temporal region,0.5382352941176471
town,place closure control strategy,0.5088235294117647
town,B cell receptor complex,0.524074074074074
town,geographical region,0.5369565217391304
town,chronic infectious disease course,0.504054054054054
town,spatiotemporal region,0.57
town,two-dimensional spatial region,0.5382352941176471
town,pathogen death temporal region,0.5382352941176471
town,latency end temporal region,0.5467741935483871
town,infection incidence rate,0.5571428571428572
town,one-dimensional spatial region,0.5382352941176471
town,long-term non-progressing infectious disease course,0.5045454545454545
Doctor,COVID-19 mortality rate,0.5879310344827586
Doctor,infectious disease mortality rate,0.5525641025641026
Doctor,establishment of a clinically abnormal colony,0.5284313725490196
Doctor,COVID-19 incidence rate,0.553448275862069
Doctor,infection incidence rate profile,0.5552631578947369
Doctor,T cell receptor complex,0.5879310344827586
Doctor,incubation end temporal region,0.5611111111111111
Doctor,plan specification,0.575
Doctor,infectious disease incidence rate,0.5525641025641026
Doctor,communicability end process boundary,0.569047619047619
Doctor,communicability end temporal region,0.5719512195121951
Doctor,infection end temporal region,0.5642857142857143
Doctor,incubation end process boundary,0.5851351351351352
Doctor,respiratory system disease,0.54375
Doctor,SARS-CoV-2 spike glycoprotein,0.5642857142857143
Doctor,latency end process boundary,0.5970588235294118
Doctor,SARS-CoV-2 incidence rate,0.5467741935483871
Doctor,B cell receptor complex,0.5879310344827586
Doctor,viral load,0.5125
Doctor,latency end temporal region,0.5712121212121213
Doctor,infection incidence rate,0.5833333333333334
Covid Care Centre (CCC),case isolation control strategy,0.6351851851851852
Covid Care Centre (CCC),single-stranded RNA retrovirus,0.6009433962264151
Covid Care Centre (CCC),double-stranded RNA virus,0.575
Covid Care Centre (CCC),negative-sense single-stranded RNA virus,0.5769841269841269
Covid Care Centre (CCC),quarantine control strategy,0.63
Covid Care Centre (CCC),establishment of a clinically abnormal colony,0.5823529411764706
Covid Care Centre (CCC),infectious disease control objective specification,0.6417808219178082
Covid Care Centre (CCC),T cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),pathogen portal of exit,0.5804347826086956
Covid Care Centre (CCC),incubation end temporal region,0.619811320754717
Covid Care Centre (CCC),SARS-CoV-2 attachment stage,0.65
Covid Care Centre (CCC),positive-sense single-stranded RNA virus,0.5928571428571429
Covid Care Centre (CCC),herd immunity to infectious organism,0.5516949152542373
Covid Care Centre (CCC),acute respiratory distress syndrome,0.6051724137931035
Covid Care Centre (CCC),infectious disease control strategy,0.6396551724137931
Covid Care Centre (CCC),communicability end process boundary,0.6364406779661017
Covid Care Centre (CCC),communicability end temporal region,0.6396551724137931
Covid Care Centre (CCC),infection end temporal region,0.6038461538461539
Covid Care Centre (CCC),virus attachment stage,0.65
Covid Care Centre (CCC),pathogen portal of exit role,0.6068627450980393
Covid Care Centre (CCC),incubation end process boundary,0.6166666666666667
Covid Care Centre (CCC),pathogen portal of exit site,0.5872549019607843
Covid Care Centre (CCC),vector control strategy,0.6456521739130434
Covid Care Centre (CCC),latency end process boundary,0.6068627450980393
Covid Care Centre (CCC),place closure control strategy,0.6575471698113208
Covid Care Centre (CCC),B cell receptor complex,0.6673913043478261
Covid Care Centre (CCC),viral load,0.5712121212121213
Covid Care Centre (CCC),latency end temporal region,0.61
Covid Care Centre (CCC),action specification,0.5895348837209302
Country wise statistics,cell space,0.6318181818181818
Country wise statistics,COVID-19 mortality rate,0.6239130434782608
Country wise statistics,infectious disease mortality rate,0.6642857142857143
Country wise statistics,country,0.6833333333333332
Country wise statistics,establishment of a clinically abnormal colony,0.5823529411764706
Country wise statistics,organism population,0.6404761904761905
Country wise statistics,material processing,0.6166666666666667
Country wise statistics,infected population,0.6166666666666667
Country wise statistics,COVID-19 incidence rate,0.6239130434782608
Country wise statistics,source of infection site,0.6627659574468084
Country wise statistics,spatial region,0.5851351351351352
Country wise statistics,SARS-CoV-2 incidence proportion,0.5981481481481481
Country wise statistics,infection incidence rate profile,0.6318181818181818
Country wise statistics,source of infection,0.6404761904761905
Country wise statistics,T cell receptor complex,0.5804347826086956
Country wise statistics,incubation end temporal region,0.619811320754717
Country wise statistics,temporal region,0.581578947368421
Country wise statistics,communicability start temporal region,0.6666666666666667
Country wise statistics,one-dimensional temporal region,0.5981481481481481
Country wise statistics,directive information content entity,0.6194915254237288
Country wise statistics,anatomical space,0.6294871794871795
Country wise statistics,three-dimensional spatial region,0.6318181818181818
Country wise statistics,source of infection role,0.6202127659574468
Country wise statistics,acute infection,0.6605263157894737
Country wise statistics,plan specification,0.6207317073170732
Country wise statistics,COVID-19 disease incidence proportion,0.6166666666666667
Country wise statistics,zero-dimensional temporal region,0.5772727272727273
Country wise statistics,information content entity,0.6336734693877552
Country wise statistics,processed material,0.6207317073170732
Country wise statistics,infectious disease incidence rate,0.6464285714285714
Country wise statistics,normal resident microbiota population,0.6166666666666667
Country wise statistics,infection start temporal region,0.6351851851851852
Country wise statistics,material entity,0.6342105263157894
Country wise statistics,process that results in death,0.6230769230769231
Country wise statistics,acute respiratory distress syndrome,0.656896551724138
Country wise statistics,geospatial region,0.6
Country wise statistics,lower respiratory tract disease,0.6537037037037037
Country wise statistics,acute infectious disease course,0.6722222222222223
Country wise statistics,communicability end process boundary,0.6364406779661017
Country wise statistics,infectious agent population,0.63
Country wise statistics,zero-dimensional spatial region,0.6166666666666667
Country wise statistics,communicability end temporal region,0.656896551724138
Country wise statistics,simple infection,0.6038461538461539
Country wise statistics,infection end temporal region,0.6230769230769231
Country wise statistics,infection incidence proportion profile,0.6139344262295081
Country wise statistics,incubation end process boundary,0.5981481481481481
Country wise statistics,latency end process boundary,0.5872549019607843
Country wise statistics,SARS-CoV-2 incidence rate,0.6166666666666667
Country wise statistics,angiotensin-converting enzyme 2,0.5796296296296296
Country wise statistics,pathogen birth temporal region,0.6009433962264151
Country wise statistics,infectious disease incidence proportion,0.6274193548387097
Country wise statistics,susceptible population,0.6277777777777778
Country wise statistics,B cell receptor complex,0.558695652173913
Country wise statistics,geographical region,0.569047619047619
Country wise statistics,immune population,0.625
Country wise statistics,active immunization against infectious agent,0.6440298507462687
Country wise statistics,spatiotemporal region,0.5863636363636363
Country wise statistics,descriptive information content entity,0.6139344262295081
Country wise statistics,two-dimensional spatial region,0.6386792452830189
Country wise statistics,pathogen death temporal region,0.6009433962264151
Country wise statistics,designative information content entity,0.6139344262295081
Country wise statistics,latency end temporal region,0.61
Country wise statistics,infection incidence rate,0.6414893617021277
Country wise statistics,diseased population,0.6166666666666667
Country wise statistics,infection incidence proportion,0.619811320754717
Country wise statistics,one-dimensional spatial region,0.6386792452830189
Organization,primary infectious disposition,0.6404761904761905
Organization,case isolation control strategy,0.6127906976744186
Organization,pathogen surveillance,0.6318181818181818
Organization,COVID-19 mortality rate,0.6214285714285714
Organization,collective pathogenic disposition,0.6277777777777778
Organization,establishment of localization in virus host,0.6136363636363636
Organization,infectious disease mortality rate,0.5833333333333334
Organization,virostatic disposition,0.6558823529411765
Organization,quarantine control strategy,0.6294871794871795
Organization,SARS-COV-2 adhesion disposition,0.636046511627907
Organization,exotoxin disposition,0.66875
Organization,negative regulation of replication,0.6673913043478261
Organization,invasive disposition,0.6375
Organization,disposition,0.7108695652173913
Organization,establishment of a clinically abnormal colony,0.5728070175438597
Organization,organism population,0.8048387096774193
Organization,negative regulation of biological process,0.6009433962264151
Organization,fungistatic disposition,0.65
Organization,asymptomatic infectious structure carrier,0.5632075471698114
Organization,disease surveillance objective specification,0.6107142857142857
Organization,immunosuppressed organism,0.6121621621621621
Organization,infectious structure aggregate,0.569047619047619
Organization,cidal agent disposition,0.65
Organization,establishment of localization,0.6695121951219513
Organization,COVID-19 incidence rate,0.5928571428571429
Organization,immunosuppressive disposition,0.6207317073170732
Organization,endotoxin disposition,0.6621212121212122
Organization,infectious disease control objective specification,0.5951612903225807
Organization,negative regulation of establishment of localization,0.621875
Organization,pathologically immunosuppressed organism,0.5846153846153846
Organization,biological regulation,0.6924242424242425
Organization,vector surveillance,0.6112903225806451
Organization,parasiticidal disposition,0.6662162162162162
Organization,neurotoxin disposition,0.6558823529411765
Organization,infection incidence rate profile,0.5863636363636363
Organization,infectious structure host,0.5581081081081081
Organization,T cell receptor complex,0.5357142857142857
Organization,static agent disposition,0.6444444444444444
Organization,acellular structure,0.5467741935483871
Organization,incubation end temporal region,0.5928571428571429
Organization,reverse zoonotic disposition,0.625
Organization,viricidal disposition,0.6621212121212122
Organization,drug-based immunosuppressed organism,0.575
Organization,opportunistic infectious disposition,0.6166666666666667
Organization,collective disposition,0.6264705882352941
Organization,plan specification,0.7166666666666667
Organization,architectual structure,0.5676470588235294
Organization,herd immunity to infectious organism,0.5958333333333333
Organization,viral adhesion disposition,0.6605263157894737
Organization,pathogenic disposition,0.6852941176470588
Organization,infectious disease incidence rate,0.5833333333333334
Organization,immunodeficient organism,0.6166666666666667
Organization,adhesion disposition,0.66875
Organization,infectious disposition,0.6264705882352941
Organization,zoonotic disposition,0.66875
Organization,bactericidal disposition,0.6444444444444444
Organization,organism,0.75
Organization,infectious disease control strategy,0.5563829787234043
Organization,establishment of localization in host,0.6336734693877552
Organization,communicability end process boundary,0.5958333333333333
Organization,negative regulation of immune response,0.61
Organization,infectious structure,0.575
Organization,infectious structure host role,0.5452380952380953
Organization,collective resistance disposition,0.65
Organization,negative regulation of production,0.6277777777777778
Organization,negative regulation of life-sustaining process,0.5879310344827586
Organization,communicability end temporal region,0.6202127659574468
Organization,negative regulation of developmental process,0.5928571428571429
Organization,infection end temporal region,0.5963414634146341
Organization,incubation end process boundary,0.5895348837209302
Organization,respiratory system disease,0.581578947368421
Organization,infectious structure generative stage,0.5928571428571429
Organization,surveillance process,0.575
Organization,vector control strategy,0.5928571428571429
Organization,latency end process boundary,0.55
Organization,SARS-CoV-2 incidence rate,0.5851351351351352
Organization,place closure control strategy,0.569047619047619
Organization,symptomatic infectious structure carrier,0.5653846153846154
Organization,B cell receptor complex,0.5357142857142857
Organization,acellular structure aggregate,0.5475609756097561
Organization,enterotoxin disposition,0.65
Organization,establishment of localization in human host,0.6136363636363636
Organization,toxin disposition,0.6913793103448276
Organization,transmissibility disposition,0.65
Organization,virulence factor disposition,0.625
Organization,latency end temporal region,0.6038461538461539
Organization,negative regulation of viral process,0.6166666666666667
Organization,invasion disposition,0.66875
Organization,extended organism,0.656896551724138
Organization,infection incidence rate,0.5888888888888889
Organization,organism substance,0.7166666666666667
Organization,susceptible organism,0.6375
Organization,parasitostatic disposition,0.6605263157894737
Organization,immunocompetent organism,0.6166666666666667
Organization,cytotoxin disposition,0.6621212121212122
Organization,fungicidal disposition,0.6558823529411765
Organization,bacteriostatic disposition,0.6342105263157894
Test result,COVID-19 mortality rate,0.5970588235294118
Test result,communicability start process boundary,0.6132653061224489
Test result,infectious disease mortality rate,0.609090909090909
Test result,establishment of a clinically abnormal colony,0.5571428571428572
Test result,COVID-19 incidence rate,0.5676470588235294
Test result,immune response,0.6423076923076922
Test result,infection incidence rate profile,0.5895348837209302
Test result,T cell receptor complex,0.6264705882352941
Test result,incubation end temporal region,0.5963414634146341
Test result,communicability start temporal region,0.575
Test result,plan specification,0.553448275862069
Test result,polymerase chain reaction,0.6166666666666667
Test result,production,0.5928571428571429
Test result,infectious disease incidence rate,0.5863636363636363
Test result,infection start temporal region,0.5928571428571429
Test result,communicability end process boundary,0.598936170212766
Test result,negative regulation of immune response,0.6132653061224489
Test result,division of geopolitical entity,0.569047619047619
Test result,negative regulation of production,0.6318181818181818
Test result,communicability end temporal region,0.5804347826086956
Test result,infection end temporal region,0.6
Test result,assay,0.575
Test result,humoral immune response,0.5970588235294118
Test result,incubation end process boundary,0.6166666666666667
Test result,innate immune response,0.6318181818181818
Test result,incubation start process boundary,0.6318181818181818
Test result,latency end process boundary,0.6294871794871795
Test result,SARS-CoV-2 incidence rate,0.5611111111111111
Test result,place closure control strategy,0.5963414634146341
Test result,B cell receptor complex,0.5970588235294118
Test result,viral plaque assay,0.553448275862069
Test result,infection start process boundary,0.636046511627907
Test result,PCR product,0.6318181818181818
Test result,serology assay,0.57
Test result,latency end temporal region,0.6078947368421053
Test result,infection incidence rate,0.5928571428571429
Test result,organism substance,0.6224137931034482
Test result,action specification,0.5790322580645162
Test result,adaptive immune response,0.6214285714285714
Test result,latency start process boundary,0.6695121951219513
InfectedNeighbor,infected population,0.7357142857142857
InfectedNeighbor,T cell receptor complex,0.5782051282051281
InfectedNeighbor,B cell receptor complex,0.5782051282051281
SecondaryContact,establishment of a clinically abnormal colony,0.5975409836065574
SecondaryContact,T cell receptor complex,0.6038461538461539
SecondaryContact,contact pathogen transmission process,0.6386792452830189
SecondaryContact,secondary infection role,0.75
SecondaryContact,secondary infection,0.7928571428571428
SecondaryContact,contact tracing,0.7080645161290323
InfectedViaPoliceWork,establishment of a clinically abnormal colony,0.6015151515151516
InfectedViaPoliceWork,infected population,0.775
InfectedViaPoliceWork,T cell receptor complex,0.609090909090909
Dedicated Covid Hospital (DCH),COVID-19 mortality rate,0.6575471698113208
Dedicated Covid Hospital (DCH),establishment of localization in virus host,0.6280821917808219
Dedicated Covid Hospital (DCH),infectious disease mortality rate,0.6246031746031746
Dedicated Covid Hospital (DCH),establishment of a clinically abnormal colony,0.61
Dedicated Covid Hospital (DCH),hospital facility,0.6627659574468084
Dedicated Covid Hospital (DCH),establishment of localization,0.6025423728813559
Dedicated Covid Hospital (DCH),COVID-19 incidence rate,0.619811320754717
Dedicated Covid Hospital (DCH),negative regulation of establishment of localization,0.6207317073170732
Dedicated Covid Hospital (DCH),infection incidence rate profile,0.6274193548387097
Dedicated Covid Hospital (DCH),T cell receptor complex,0.619811320754717
Dedicated Covid Hospital (DCH),incubation end temporal region,0.6333333333333333
Dedicated Covid Hospital (DCH),infectious disease incidence rate,0.6246031746031746
Dedicated Covid Hospital (DCH),establishment of localization in host,0.6291044776119403
Dedicated Covid Hospital (DCH),communicability end process boundary,0.6166666666666667
Dedicated Covid Hospital (DCH),communicability end temporal region,0.6192307692307693
Dedicated Covid Hospital (DCH),infection end temporal region,0.6194915254237288
Dedicated Covid Hospital (DCH),incubation end process boundary,0.630327868852459
Dedicated Covid Hospital (DCH),respiratory system disease,0.6285714285714286
Dedicated Covid Hospital (DCH),latency end process boundary,0.6224137931034482
Dedicated Covid Hospital (DCH),SARS-CoV-2 incidence rate,0.5954545454545455
Dedicated Covid Hospital (DCH),place closure control strategy,0.6166666666666667
Dedicated Covid Hospital (DCH),B cell receptor complex,0.619811320754717
Dedicated Covid Hospital (DCH),active immunization against infectious agent,0.5851351351351352
Dedicated Covid Hospital (DCH),establishment of localization in human host,0.6143835616438357
Dedicated Covid Hospital (DCH),latency end temporal region,0.6254385964912281
Dedicated Covid Hospital (DCH),infection incidence rate,0.6166666666666667
Severe COVID-19,COVID-19 mortality rate,0.6605263157894737
Severe COVID-19,infectious disease mortality rate,0.575
Severe COVID-19,COVID-19 prevalence,0.6852941176470588
Severe COVID-19,establishment of a clinically abnormal colony,0.55
Severe COVID-19,pathogen portal of entry site,0.5636363636363636
Severe COVID-19,COVID-19 incidence rate,0.6605263157894737
Severe COVID-19,COVID-19 epidemic,0.7
Severe COVID-19,source of infection site,0.6294871794871795
Severe COVID-19,COVID-19 sporadicity,0.6785714285714286
Severe COVID-19,COVID-19,0.7978260869565217
Severe COVID-19,COVID-19 pandemic,0.7
Severe COVID-19,infection incidence rate profile,0.598936170212766
Severe COVID-19,T cell receptor complex,0.6078947368421053
Severe COVID-19,incubation end temporal region,0.5611111111111111
Severe COVID-19,COVID-19 disease course,0.6605263157894737
Severe COVID-19,site of infection,0.60625
Severe COVID-19,acute infection,0.5833333333333334
Severe COVID-19,COVID-19 disease incidence proportion,0.6038461538461539
Severe COVID-19,COVID-19 lifetime prevalence,0.636046511627907
Severe COVID-19,COVID-19 incidence,0.6924242424242425
Severe COVID-19,infectious disease incidence rate,0.5958333333333333
Severe COVID-19,site,0.5552631578947369
Severe COVID-19,epitope site,0.5981481481481481
Severe COVID-19,acute respiratory distress syndrome,0.57
Severe COVID-19,acute infectious disease course,0.5804347826086956
Severe COVID-19,communicability end process boundary,0.5676470588235294
Severe COVID-19,COVID-19 endemicity,0.6852941176470588
Severe COVID-19,communicability end temporal region,0.55
Severe COVID-19,simple infection,0.6112903225806451
Severe COVID-19,infection end temporal region,0.5636363636363636
Severe COVID-19,incubation end process boundary,0.5804347826086956
Severe COVID-19,respiratory system disease,0.5719512195121951
Severe COVID-19,pathogen portal of exit site,0.5662790697674418
Severe COVID-19,latency end process boundary,0.6127906976744186
Severe COVID-19,SARS-CoV-2 incidence rate,0.625
Severe COVID-19,systematic infection,0.5928571428571429
Severe COVID-19,B cell receptor complex,0.6078947368421053
Severe COVID-19,latency end temporal region,0.569047619047619
Severe COVID-19,infection incidence rate,0.5782051282051281
Geographic Region,objective specification,0.625
Geographic Region,infectious disease course,0.5928571428571429
Geographic Region,country,0.575
Geographic Region,establishment of a clinically abnormal colony,0.5951612903225807
Geographic Region,local infection,0.66875
Geographic Region,disease surveillance objective specification,0.5975409836065574
Geographic Region,coronavirus disease course,0.6127906976744186
Geographic Region,infectious disease control objective specification,0.5843283582089552
Geographic Region,spatial region,0.7403225806451613
Geographic Region,viral disease course,0.6121621621621621
Geographic Region,object aggregate,0.6318181818181818
Geographic Region,object,0.5369565217391304
Geographic Region,SARS-CoV-2 incidence proportion,0.6166666666666667
Geographic Region,T cell receptor complex,0.575
Geographic Region,incubation end temporal region,0.6840425531914894
Geographic Region,temporal region,0.79375
Geographic Region,COVID-19 disease course,0.575
Geographic Region,communicability start temporal region,0.6537037037037037
Geographic Region,one-dimensional temporal region,0.6791666666666666
Geographic Region,three-dimensional spatial region,0.6948979591836735
Geographic Region,COVID-19 disease incidence proportion,0.6166666666666667
Geographic Region,zero-dimensional temporal region,0.6744897959183673
Geographic Region,infection start temporal region,0.6791666666666666
Geographic Region,geospatial region,0.8029411764705883
Geographic Region,lower respiratory tract disease,0.5958333333333333
Geographic Region,acute infectious disease course,0.575
Geographic Region,communicability end process boundary,0.6009433962264151
Geographic Region,division of geopolitical entity,0.6375
Geographic Region,disease course,0.6112903225806451
Geographic Region,zero-dimensional spatial region,0.7
Geographic Region,communicability end temporal region,0.6615384615384616
Geographic Region,infection end temporal region,0.6891304347826087
Geographic Region,infection incidence proportion profile,0.6136363636363636
Geographic Region,incubation end process boundary,0.5958333333333333
Geographic Region,latency end process boundary,0.6055555555555556
Geographic Region,pathogen birth temporal region,0.7053191489361703
Geographic Region,place closure control strategy,0.6202127659574468
Geographic Region,infectious disease incidence proportion,0.6285714285714286
Geographic Region,B cell receptor complex,0.575
Geographic Region,geographical region,0.9222222222222223
Geographic Region,chronic infectious disease course,0.59
Geographic Region,spatiotemporal region,0.7394736842105263
Geographic Region,two-dimensional spatial region,0.7053191489361703
Geographic Region,pathogen death temporal region,0.7053191489361703
Geographic Region,latency end temporal region,0.7
Geographic Region,infection incidence proportion,0.6414893617021277
Geographic Region,one-dimensional spatial region,0.7053191489361703
Geographic Region,long-term non-progressing infectious disease course,0.5970588235294118
State,case isolation control strategy,0.5888888888888889
State,COVID-19 mortality rate,0.5928571428571429
State,infectious disease mortality rate,0.581578947368421
State,establishment of a clinically abnormal colony,0.53
State,pathogen portal of entry site,0.5676470588235294
State,COVID-19 incidence rate,0.5571428571428572
State,source of infection site,0.5879310344827586
State,infection incidence rate profile,0.5581081081081081
State,T cell receptor complex,0.5571428571428572
State,incubation end temporal region,0.5357142857142857
State,site of infection,0.5863636363636363
State,infectious disease incidence rate,0.5552631578947369
State,site,0.7833333333333333
State,epitope site,0.6264705882352941
State,communicability end process boundary,0.523170731707317
State,communicability end temporal region,0.525
State,infection end temporal region,0.5382352941176471
State,incubation end process boundary,0.5333333333333333
State,pathogen portal of exit site,0.5712121212121213
State,latency end process boundary,0.5409090909090909
State,SARS-CoV-2 incidence rate,0.5833333333333334
State,B cell receptor complex,0.5214285714285714
State,latency end temporal region,0.54375
State,infection incidence rate,0.5879310344827586
Clinical finding (finding),single-stranded RNA retrovirus,0.5928571428571429
Clinical finding (finding),objective specification,0.6132653061224489
Clinical finding (finding),double-stranded RNA virus,0.5872549019607843
Clinical finding (finding),negative-sense single-stranded RNA virus,0.6015151515151516
Clinical finding (finding),establishment of a clinically abnormal colony,0.6190140845070422
Clinical finding (finding),disease surveillance objective specification,0.6071428571428572
Clinical finding (finding),infectious disease control objective specification,0.6078947368421053
Clinical finding (finding),object aggregate,0.5452380952380953
Clinical finding (finding),T cell receptor complex,0.5520408163265306
Clinical finding (finding),incubation end temporal region,0.6464285714285714
Clinical finding (finding),positive-sense single-stranded RNA virus,0.5863636363636363
Clinical finding (finding),lower respiratory tract disease,0.5728070175438597
Clinical finding (finding),communicability end process boundary,0.6435483870967742
Clinical finding (finding),communicability end temporal region,0.6467213114754098
Clinical finding (finding),infection end temporal region,0.6318181818181818
Clinical finding (finding),incubation end process boundary,0.6254385964912281
Clinical finding (finding),latency end process boundary,0.6166666666666667
Clinical finding (finding),B cell receptor complex,0.5520408163265306
Clinical finding (finding),active immunization against infectious agent,0.65
Clinical finding (finding),latency end temporal region,0.619811320754717
Gender type,case isolation control strategy,0.5928571428571429
Gender type,COVID-19 mortality rate,0.5970588235294118
Gender type,infectious disease mortality rate,0.609090909090909
Gender type,establishment of a clinically abnormal colony,0.5392857142857143
Gender type,COVID-19 incidence rate,0.6264705882352941
Gender type,complex infection,0.5928571428571429
Gender type,infection incidence rate profile,0.636046511627907
Gender type,T cell receptor complex,0.6264705882352941
Gender type,immunoglobulin complex,0.6015151515151516
Gender type,incubation end temporal region,0.6207317073170732
Gender type,infectious disease incidence rate,0.609090909090909
Gender type,lower respiratory tract disease,0.5928571428571429
Gender type,communicability end process boundary,0.5776595744680851
Gender type,division of geopolitical entity,0.569047619047619
Gender type,communicability end temporal region,0.6021739130434782
Gender type,infection end temporal region,0.625
Gender type,incubation end process boundary,0.5928571428571429
Gender type,respiratory system disease,0.5851351351351352
Gender type,latency end process boundary,0.6038461538461539
Gender type,SARS-CoV-2 incidence rate,0.6166666666666667
Gender type,B cell receptor complex,0.6264705882352941
Gender type,macromolecular complex,0.6015151515151516
Gender type,latency end temporal region,0.6342105263157894
Gender type,infection incidence rate,0.65
Gender type,action specification,0.5790322580645162
Viral disease,primary infectious disposition,0.6127906976744186
Viral disease,process of establishing viral infection,0.6038461538461539
Viral disease,virus adhesion susceptible cell,0.6545454545454545
Viral disease,viral capsid,0.77
Viral disease,single-stranded DNA virus,0.6342105263157894
Viral disease,SARS-CoV-2 disorder,0.6375
Viral disease,virus release stage,0.7
Viral disease,virus translation stage,0.7
Viral disease,subclinical infection,0.6264705882352941
Viral disease,double-stranded RNA virus,0.6078947368421053
Viral disease,collective pathogenic disposition,0.6021739130434782
Viral disease,infectious disease endemicity,0.6642857142857143
Viral disease,infection,0.5409090909090909
Viral disease,establishment of localization in virus host,0.575
Viral disease,negative-sense single-stranded RNA virus,0.6009433962264151
Viral disease,infectious disease course,0.6868421052631578
Viral disease,infectious disease mortality rate,0.6456521739130434
Viral disease,virostatic disposition,0.7071428571428571
Viral disease,SARS-COV-2 adhesion disposition,0.609090909090909
Viral disease,exotoxin disposition,0.6318181818181818
Viral disease,virus synthesis stage,0.6852941176470588
Viral disease,invasive disposition,0.6621212121212122
Viral disease,disposition,0.6166666666666667
Viral disease,viral disease pandemic,0.8214285714285714
Viral disease,establishment of a clinically abnormal colony,0.553448275862069
Viral disease,nursing-home acquired infection,0.5636363636363636
Viral disease,local infection,0.6285714285714286
Viral disease,fungistatic disposition,0.6444444444444444
Viral disease,disease surveillance objective specification,0.5903508771929825
Viral disease,cidal agent disposition,0.6722222222222223
Viral disease,COVID-19 epidemic,0.6166666666666667
Viral disease,complex infection,0.5833333333333334
Viral disease,immunosuppressive disposition,0.6166666666666667
Viral disease,endotoxin disposition,0.6264705882352941
Viral disease,source of infection site,0.6121621621621621
Viral disease,infectious disease sporadicity,0.6593023255813953
Viral disease,coronavirus disease course,0.732051282051282
Viral disease,disordered virus,0.6224137931034482
Viral disease,infectious disease control objective specification,0.5928571428571429
Viral disease,viral disease course,0.8439393939393939
Viral disease,infectious disease epidemic,0.675
Viral disease,parasiticidal disposition,0.6605263157894737
Viral disease,neurotoxin disposition,0.6214285714285714
Viral disease,infectious disease,0.7403225806451613
Viral disease,intracellular infection,0.6444444444444444
Viral disease,infection incidence rate profile,0.5833333333333334
Viral disease,source of infection,0.575
Viral disease,T cell receptor complex,0.5611111111111111
Viral disease,viral pathogenesis,0.7080645161290323
Viral disease,static agent disposition,0.6391891891891892
Viral disease,viral disease epidemic,0.8214285714285714
Viral disease,incubation end temporal region,0.6127906976744186
Viral disease,reverse zoonotic disposition,0.6207317073170732
Viral disease,COVID-19 disease course,0.7277777777777777
Viral disease,viricidal disposition,0.7441176470588234
Viral disease,viral disease,0.95
Viral disease,disease,0.8
Viral disease,opportunistic infectious disposition,0.5724489795918367
Viral disease,site of infection,0.5833333333333334
Viral disease,positive-sense single-stranded RNA virus,0.6009433962264151
Viral disease,collective disposition,0.6214285714285714
Viral disease,source of infection role,0.5851351351351352
Viral disease,hospital-acquired infection,0.6
Viral disease,primary infection,0.6166666666666667
Viral disease,acute infection,0.5928571428571429
Viral disease,COVID-19 disease incidence proportion,0.65
Viral disease,infection incidence,0.60625
Viral disease,coronavirus disease,0.79375
Viral disease,viral adhesion disposition,0.7064102564102563
Viral disease,virus disorder,0.7462962962962962
Viral disease,pathogenic disposition,0.6214285714285714
Viral disease,virus aggregate,0.7
Viral disease,virus generative stage,0.6785714285714286
Viral disease,infectious disease incidence rate,0.6456521739130434
Viral disease,community-acquired infection,0.5719512195121951
Viral disease,adhesion disposition,0.6318181818181818
Viral disease,infection start temporal region,0.5863636363636363
Viral disease,infectious disposition,0.6214285714285714
Viral disease,virus replication,0.65
Viral disease,viral envelope,0.7462962962962962
Viral disease,chronic infection,0.5833333333333334
Viral disease,zoonotic disposition,0.6318181818181818
Viral disease,bactericidal disposition,0.6662162162162162
Viral disease,disorder,0.6404761904761905
Viral disease,acute respiratory distress syndrome,0.6583333333333334
Viral disease,infectious disease prevalence,0.6642857142857143
Viral disease,lower respiratory tract disease,0.7
Viral disease,primary infection role,0.6214285714285714
Viral disease,acute infectious disease course,0.6545454545454545
Viral disease,infectious disease control strategy,0.6375
Viral disease,communicability end process boundary,0.5928571428571429
Viral disease,collective resistance disposition,0.6239130434782608
Viral disease,subclinical SARS-CoV-2 infection,0.6277777777777778
Viral disease,disease course,0.7092592592592593
Viral disease,communicability end temporal region,0.6166666666666667
Viral disease,simple infection,0.6224137931034482
Viral disease,infection end temporal region,0.5928571428571429
Viral disease,infectious disease incidence,0.6695121951219513
Viral disease,infectious disease pandemic,0.675
Viral disease,disease transmission model,0.6294871794871795
Viral disease,virus attachment stage,0.6785714285714286
Viral disease,process of establishing an infection,0.5928571428571429
Viral disease,infection incidence proportion profile,0.5480392156862746
Viral disease,incubation end process boundary,0.5863636363636363
Viral disease,infection incidence profile,0.575
Viral disease,respiratory system disease,0.732051282051282
Viral disease,respiratory droplet virus fomite,0.6277777777777778
Viral disease,latency end process boundary,0.5719512195121951
Viral disease,infection prevalence,0.6318181818181818
Viral disease,infectious disorder,0.6375
Viral disease,systematic infection,0.5712121212121213
Viral disease,infectious disease incidence proportion,0.6230769230769231
Viral disease,double-stranded DNA virus,0.6078947368421053
Viral disease,B cell receptor complex,0.5611111111111111
Viral disease,secondary infection role,0.5851351351351352
Viral disease,enterotoxin disposition,0.6166666666666667
Viral disease,viral plaque assay,0.7403225806451613
Viral disease,chronic infectious disease course,0.6456521739130434
Viral disease,virus uncoating stage,0.6852941176470588
Viral disease,infectious disease lifetime prevalence,0.6264705882352941
Viral disease,appearance of disorder,0.65
Viral disease,toxin disposition,0.65
Viral disease,secondary infection,0.575
Viral disease,virus penetration stage,0.6722222222222223
Viral disease,infection start process boundary,0.5611111111111111
Viral disease,transmissibility disposition,0.6451219512195122
Viral disease,viral load,0.7543478260869566
Viral disease,virus host,0.6673913043478261
Viral disease,virulence factor disposition,0.6695121951219513
Viral disease,latency end temporal region,0.6
Viral disease,negative regulation of viral process,0.6132653061224489
Viral disease,invasion disposition,0.6621212121212122
Viral disease,infection incidence rate,0.6121621621621621
Viral disease,virus,0.6722222222222223
Viral disease,subclinical virus infection,0.625
Viral disease,extracellular infection,0.6166666666666667
Viral disease,subclinical coronavirus infection,0.6021739130434782
Viral disease,parasitostatic disposition,0.6294871794871795
Viral disease,metastatic infection,0.5712121212121213
Viral disease,infection incidence proportion,0.5662790697674418
Viral disease,cytotoxin disposition,0.6264705882352941
Viral disease,long-term non-progressing infectious disease course,0.590625
Viral disease,fungicidal disposition,0.6785714285714286
Viral disease,coronavirus disorder,0.6924242424242425
Viral disease,bacteriostatic disposition,0.6294871794871795
Viral disease,virus transcription stage,0.6605263157894737
HealthCareProfessional,establishment of a clinically abnormal colony,0.6141791044776119
HealthCareProfessional,T cell receptor complex,0.6277777777777778
HealthCareProfessional,healthcare facility,0.7670731707317073
Laboratory test finding,primary infectious disposition,0.6575471698113208
Laboratory test finding,single-stranded RNA retrovirus,0.6009433962264151
Laboratory test finding,virus release stage,0.5928571428571429
Laboratory test finding,virus translation stage,0.6239130434782608
Laboratory test finding,COVID-19 mortality rate,0.6239130434782608
Laboratory test finding,double-stranded RNA virus,0.5958333333333333
Laboratory test finding,negative-sense single-stranded RNA virus,0.5928571428571429
Laboratory test finding,infectious disease mortality rate,0.6107142857142857
Laboratory test finding,virus synthesis stage,0.609090909090909
Laboratory test finding,establishment of a clinically abnormal colony,0.5970588235294118
Laboratory test finding,adhesion factor,0.6078947368421053
Laboratory test finding,COVID-19 incidence rate,0.5804347826086956
Laboratory test finding,primary pathogen,0.6551282051282051
Laboratory test finding,infection incidence rate profile,0.5954545454545455
Laboratory test finding,T cell receptor complex,0.6021739130434782
Laboratory test finding,incubation end temporal region,0.6386792452830189
Laboratory test finding,SARS-CoV-2 attachment stage,0.63
Laboratory test finding,invasion factor,0.6078947368421053
Laboratory test finding,SARS-CoV-2 uncoating stage,0.6132653061224489
Laboratory test finding,SARS-CoV-2 transcription stage,0.6386792452830189
Laboratory test finding,positive-sense single-stranded RNA virus,0.5928571428571429
Laboratory test finding,primary infection,0.675
Laboratory test finding,generative stage,0.6294871794871795
Laboratory test finding,pathogen generative stage,0.6375
Laboratory test finding,virus generative stage,0.6055555555555556
Laboratory test finding,infectious disease incidence rate,0.6285714285714286
Laboratory test finding,lower respiratory tract disease,0.7092592592592593
Laboratory test finding,primary infection role,0.65
Laboratory test finding,communicability end process boundary,0.6194915254237288
Laboratory test finding,SARS-CoV-2 release stage,0.6202127659574468
Laboratory test finding,division of geopolitical entity,0.5981481481481481
Laboratory test finding,developmental process,0.5863636363636363
Laboratory test finding,communicability end temporal region,0.6224137931034482
Laboratory test finding,negative regulation of developmental process,0.5843283582089552
Laboratory test finding,infection end temporal region,0.6038461538461539
Laboratory test finding,assay,0.5571428571428572
Laboratory test finding,SARS-CoV-2 synthesis stage,0.6336734693877552
Laboratory test finding,virus attachment stage,0.6277777777777778
Laboratory test finding,incubation end process boundary,0.6351851851851852
Laboratory test finding,infectious structure generative stage,0.6166666666666667
Laboratory test finding,latency end process boundary,0.6460784313725491
Laboratory test finding,SARS-CoV-2 incidence rate,0.6166666666666667
Laboratory test finding,B cell receptor complex,0.6021739130434782
Laboratory test finding,SARS-CoV-2 penetration stage,0.6460784313725491
Laboratory test finding,viral plaque assay,0.5719512195121951
Laboratory test finding,virus uncoating stage,0.609090909090909
Laboratory test finding,virus penetration stage,0.6239130434782608
Laboratory test finding,serology assay,0.5851351351351352
Laboratory test finding,virulence factor disposition,0.6460784313725491
Laboratory test finding,latency end temporal region,0.65
Laboratory test finding,infection incidence rate,0.598936170212766
Laboratory test finding,SARS-CoV-2 genome replication stage,0.6224137931034482
Laboratory test finding,primary immunodeficiency,0.6627659574468084
Laboratory test finding,virulence factor,0.5782051282051281
Laboratory test finding,infectious agent generative stage,0.6107142857142857
Laboratory test finding,virus transcription stage,0.6166666666666667
Country,cell space,0.5088235294117647
Country,COVID-19 mortality rate,0.5833333333333334
Country,infectious disease mortality rate,0.575
Country,country,0.95
Country,establishment of a clinically abnormal colony,0.5269230769230769
Country,COVID-19 incidence rate,0.5833333333333334
Country,spatial region,0.5452380952380953
Country,SARS-CoV-2 incidence proportion,0.5552631578947369
Country,infection incidence rate profile,0.5782051282051281
Country,T cell receptor complex,0.55
Country,incubation end temporal region,0.5851351351351352
Country,temporal region,0.5409090909090909
Country,communicability start temporal region,0.5863636363636363
Country,one-dimensional temporal region,0.5552631578947369
Country,anatomical space,0.5369565217391304
Country,three-dimensional spatial region,0.5525641025641026
Country,COVID-19 disease incidence proportion,0.5409090909090909
Country,zero-dimensional temporal region,0.5525641025641026
Country,infectious disease incidence rate,0.575
Country,infection start temporal region,0.581578947368421
Country,geospatial region,0.575
Country,communicability end process boundary,0.6127906976744186
Country,zero-dimensional spatial region,0.5552631578947369
Country,communicability end temporal region,0.5928571428571429
Country,simple infection,0.5804347826086956
Country,infection end temporal region,0.5888888888888889
Country,infection incidence proportion profile,0.5611111111111111
Country,incubation end process boundary,0.6078947368421053
Country,latency end process boundary,0.6214285714285714
Country,SARS-CoV-2 incidence rate,0.575
Country,pathogen birth temporal region,0.5581081081081081
Country,infectious disease incidence proportion,0.558695652173913
Country,B cell receptor complex,0.55
Country,geographical region,0.5653846153846154
Country,spatiotemporal region,0.5571428571428572
Country,two-dimensional spatial region,0.5581081081081081
Country,pathogen death temporal region,0.5581081081081081
Country,latency end temporal region,0.5676470588235294
Country,infection incidence rate,0.5790322580645162
Country,infection incidence proportion,0.5581081081081081
Country,one-dimensional spatial region,0.5581081081081081
Nurse,T cell receptor complex,0.5214285714285714
Nurse,incubation end temporal region,0.5642857142857143
Nurse,lower respiratory tract disease,0.5333333333333333
Nurse,communicability end process boundary,0.523170731707317
Nurse,communicability end temporal region,0.525
Nurse,infection end temporal region,0.5382352941176471
Nurse,incubation end process boundary,0.5611111111111111
Nurse,latency end process boundary,0.5409090909090909
Nurse,B cell receptor complex,0.5214285714285714
Nurse,latency end temporal region,0.54375
Professional nurse,establishment of localization in virus host,0.6139344262295081
Professional nurse,establishment of a clinically abnormal colony,0.6087301587301588
Professional nurse,establishment of localization,0.598936170212766
Professional nurse,negative regulation of establishment of localization,0.5928571428571429
Professional nurse,T cell receptor complex,0.5719512195121951
Professional nurse,incubation end temporal region,0.6166666666666667
Professional nurse,lower respiratory tract disease,0.6336734693877552
Professional nurse,establishment of localization in host,0.6136363636363636
Professional nurse,communicability end process boundary,0.6351851851851852
Professional nurse,communicability end temporal region,0.6009433962264151
Professional nurse,infection end temporal region,0.6627659574468084
Professional nurse,incubation end process boundary,0.6540816326530612
Professional nurse,latency end process boundary,0.6673913043478261
Professional nurse,B cell receptor complex,0.5719512195121951
Professional nurse,establishment of localization in human host,0.6139344262295081
Professional nurse,latency end temporal region,0.6055555555555556
Province,case isolation control strategy,0.5782051282051281
Province,reagent role,0.6
Province,dead-end host role,0.5653846153846154
Province,COVID-19 mortality rate,0.5790322580645162
Province,infectious disease mortality rate,0.5475609756097561
Province,establishment of a clinically abnormal colony,0.5254716981132076
Province,biological vector role,0.5833333333333334
Province,mutualist role,0.5863636363636363
Province,infectious agent colony,0.5790322580645162
Province,COVID-19 incidence rate,0.6435483870967742
Province,parasite role,0.6404761904761905
Province,source of infection site,0.6375
Province,symptomatic carrier role,0.60625
Province,spatial region,0.6318181818181818
Province,infection incidence rate profile,0.575
Province,source of infection,0.6351851851851852
Province,T cell receptor complex,0.5790322580645162
Province,incubation end temporal region,0.5552631578947369
Province,temporal region,0.6239130434782608
Province,communicability start temporal region,0.5388888888888889
Province,mechanical vector role,0.55
Province,function,0.575
Province,one-dimensional temporal region,0.5525641025641026
Province,three-dimensional spatial region,0.55
Province,source of infection role,0.6375
Province,pathogen host role,0.6038461538461539
Province,pathogen portal of entry role,0.5851351351351352
Province,antigen role,0.6
Province,zero-dimensional temporal region,0.575
Province,infectious disease incidence rate,0.5719512195121951
Province,colony,0.5928571428571429
Province,infection start temporal region,0.5525641025641026
Province,pathogen vehicle role,0.656896551724138
Province,geospatial region,0.61
Province,lower respiratory tract disease,0.5782051282051281
Province,primary infection role,0.65
Province,pathogen transporter role,0.5712121212121213
Province,symbiont host role,0.5653846153846154
Province,communicability end process boundary,0.5636363636363636
Province,infectious structure host role,0.5552631578947369
Province,division of geopolitical entity,0.5782051282051281
Province,zero-dimensional spatial region,0.5782051282051281
Province,communicability end temporal region,0.5430232558139535
Province,infection end temporal region,0.5581081081081081
Province,host role,0.6264705882352941
Province,fomite role,0.6078947368421053
Province,biological role,0.6239130434782608
Province,biological vehicle role,0.6112903225806451
Province,role,0.7
Province,pathogen portal of exit role,0.5888888888888889
Province,incubation end process boundary,0.5782051282051281
Province,latency end process boundary,0.5888888888888889
Province,asymptomatic carrier role,0.6015151515151516
Province,SARS-CoV-2 incidence rate,0.6621212121212122
Province,symbiont role,0.5928571428571429
Province,intermediate host role,0.55
Province,pathogen birth temporal region,0.581578947368421
Province,quality,0.5166666666666666
Province,epitope role,0.65
Province,B cell receptor complex,0.5790322580645162
Province,geographical region,0.5981481481481481
Province,secondary infection role,0.60625
Province,spatiotemporal region,0.5879310344827586
Province,commensal role,0.5863636363636363
Province,two-dimensional spatial region,0.5552631578947369
Province,pathogen vector role,0.6285714285714286
Province,reservoir of pathogen role,0.5970588235294118
Province,definitive host role,0.5571428571428572
Province,pathogen death temporal region,0.5552631578947369
Province,infectious agent host role,0.5676470588235294
Province,latency end temporal region,0.5642857142857143
Province,infection incidence rate,0.60625
Province,action specification,0.5571428571428572
Province,one-dimensional spatial region,0.5552631578947369
COVID-19 Diagnosis,virus translation stage,0.6451219512195122
COVID-19 Diagnosis,COVID-19 mortality rate,0.7182926829268292
COVID-19 Diagnosis,COVID-19 prevalence,0.7472972972972972
COVID-19 Diagnosis,establishment of a clinically abnormal colony,0.5452380952380953
COVID-19 Diagnosis,COVID-19 incidence rate,0.7426829268292683
COVID-19 Diagnosis,COVID-19 epidemic,0.7642857142857143
COVID-19 Diagnosis,COVID-19 sporadicity,0.7657894736842106
COVID-19 Diagnosis,COVID-19,0.7576923076923078
COVID-19 Diagnosis,COVID-19 pandemic,0.7928571428571428
COVID-19 Diagnosis,genetic resistance to pathogen,0.575
COVID-19 Diagnosis,T cell receptor complex,0.5475609756097561
COVID-19 Diagnosis,incubation end temporal region,0.5958333333333333
COVID-19 Diagnosis,COVID-19 disease course,0.7914634146341464
COVID-19 Diagnosis,acute infection,0.6015151515151516
COVID-19 Diagnosis,plan specification,0.5888888888888889
COVID-19 Diagnosis,COVID-19 disease incidence proportion,0.7227272727272727
COVID-19 Diagnosis,COVID-19 lifetime prevalence,0.7108695652173913
COVID-19 Diagnosis,COVID-19 incidence,0.7833333333333333
COVID-19 Diagnosis,acute respiratory distress syndrome,0.5820754716981132
COVID-19 Diagnosis,acute infectious disease course,0.6132653061224489
COVID-19 Diagnosis,geospatial location,0.5851351351351352
COVID-19 Diagnosis,communicability end process boundary,0.5981481481481481
COVID-19 Diagnosis,COVID-19 endemicity,0.7743243243243243
COVID-19 Diagnosis,division of geopolitical entity,0.5928571428571429
COVID-19 Diagnosis,communicability end temporal region,0.6009433962264151
COVID-19 Diagnosis,infection end temporal region,0.598936170212766
COVID-19 Diagnosis,incubation end process boundary,0.5928571428571429
COVID-19 Diagnosis,latency end process boundary,0.5804347826086956
COVID-19 Diagnosis,place closure control strategy,0.575
COVID-19 Diagnosis,quality,0.53
COVID-19 Diagnosis,B cell receptor complex,0.5475609756097561
COVID-19 Diagnosis,SARS-CoV-2 penetration stage,0.6239130434782608
COVID-19 Diagnosis,virus penetration stage,0.5963414634146341
COVID-19 Diagnosis,latency end temporal region,0.5833333333333334
Vital signs,primary infectious disposition,0.5963414634146341
Vital signs,pathogen death process boundary,0.569047619047619
Vital signs,COVID-19 mortality rate,0.6264705882352941
Vital signs,infectious disease mortality rate,0.5636363636363636
Vital signs,establishment of a clinically abnormal colony,0.5571428571428572
Vital signs,pathogen portal of entry site,0.6
Vital signs,COVID-19 incidence rate,0.5970588235294118
Vital signs,source of infection site,0.5928571428571429
Vital signs,primary pathogen,0.6351851851851852
Vital signs,infection incidence rate profile,0.5662790697674418
Vital signs,T cell receptor complex,0.5382352941176471
Vital signs,incubation end temporal region,0.6207317073170732
Vital signs,blood,0.5125
Vital signs,site of infection,0.6285714285714286
Vital signs,primary infection,0.6285714285714286
Vital signs,generative stage,0.5981481481481481
Vital signs,pathogen generative stage,0.5888888888888889
Vital signs,virus generative stage,0.6318181818181818
Vital signs,infectious disease incidence rate,0.5863636363636363
Vital signs,process that results in death,0.6
Vital signs,site,0.5833333333333334
Vital signs,epitope site,0.6673913043478261
Vital signs,primary infection role,0.6015151515151516
Vital signs,communicability end process boundary,0.5776595744680851
Vital signs,communicability end temporal region,0.6021739130434782
Vital signs,infection end temporal region,0.625
Vital signs,incubation end process boundary,0.569047619047619
Vital signs,respiratory system disease,0.6121621621621621
Vital signs,pathogen portal of exit site,0.6038461538461539
Vital signs,infectious structure generative stage,0.5958333333333333
Vital signs,latency end process boundary,0.5525641025641026
Vital signs,SARS-CoV-2 incidence rate,0.5611111111111111
Vital signs,B cell receptor complex,0.5088235294117647
Vital signs,active immunization against infectious agent,0.5954545454545455
Vital signs,pathogen death temporal region,0.5963414634146341
Vital signs,symptom,0.5055555555555555
Vital signs,latency end temporal region,0.6078947368421053
Vital signs,infection incidence rate,0.5928571428571429
Vital signs,primary immunodeficiency,0.5928571428571429
Vital signs,infectious agent generative stage,0.609090909090909
SecurityGuard,establishment of a clinically abnormal colony,0.5706896551724138
SecurityGuard,T cell receptor complex,0.5611111111111111
Untested for COVID-19,COVID-19 mortality rate,0.6318181818181818
Untested for COVID-19,infectious disease mortality rate,0.6166666666666667
Untested for COVID-19,COVID-19 prevalence,0.65
Untested for COVID-19,establishment of a clinically abnormal colony,0.6166666666666667
Untested for COVID-19,COVID-19 incidence rate,0.6318181818181818
Untested for COVID-19,COVID-19 epidemic,0.6605263157894737
Untested for COVID-19,COVID-19 sporadicity,0.6451219512195122
Untested for COVID-19,COVID-19,0.7258620689655172
Untested for COVID-19,COVID-19 pandemic,0.6605263157894737
Untested for COVID-19,infection incidence rate profile,0.619811320754717
Untested for COVID-19,T cell receptor complex,0.6318181818181818
Untested for COVID-19,COVID-19 disease course,0.6318181818181818
Untested for COVID-19,COVID-19 disease incidence proportion,0.5879310344827586
Untested for COVID-19,COVID-19 lifetime prevalence,0.6132653061224489
Untested for COVID-19,COVID-19 incidence,0.6551282051282051
Untested for COVID-19,infectious disease incidence rate,0.6166666666666667
Untested for COVID-19,COVID-19 endemicity,0.65
Untested for COVID-19,SARS-CoV-2 incidence rate,0.6021739130434782
Untested for COVID-19,B cell receptor complex,0.609090909090909
Untested for COVID-19,infection incidence rate,0.6277777777777778
Exposure to COVID-19,COVID-19 mortality rate,0.636046511627907
Exposure to COVID-19,drug susceptibility,0.5782051282051281
Exposure to COVID-19,susceptibility to infectious agent,0.6166666666666667
Exposure to COVID-19,COVID-19 prevalence,0.6551282051282051
Exposure to COVID-19,establishment of a clinically abnormal colony,0.573076923076923
Exposure to COVID-19,susceptibility,0.5970588235294118
Exposure to COVID-19,drug susceptibility of infectious agent,0.5855932203389831
Exposure to COVID-19,COVID-19 incidence rate,0.636046511627907
Exposure to COVID-19,COVID-19 epidemic,0.6662162162162162
Exposure to COVID-19,COVID-19 sporadicity,0.65
Exposure to COVID-19,COVID-19,0.7357142857142857
Exposure to COVID-19,COVID-19 pandemic,0.6662162162162162
Exposure to COVID-19,T cell receptor complex,0.636046511627907
Exposure to COVID-19,incubation end temporal region,0.59
Exposure to COVID-19,COVID-19 disease course,0.636046511627907
Exposure to COVID-19,COVID-19 disease incidence proportion,0.5903508771929825
Exposure to COVID-19,COVID-19 lifetime prevalence,0.6166666666666667
Exposure to COVID-19,COVID-19 incidence,0.6605263157894737
Exposure to COVID-19,communicability end process boundary,0.5928571428571429
Exposure to COVID-19,COVID-19 endemicity,0.6551282051282051
Exposure to COVID-19,communicability end temporal region,0.5954545454545455
Exposure to COVID-19,infection end temporal region,0.6132653061224489
Exposure to COVID-19,incubation end process boundary,0.5872549019607843
Exposure to COVID-19,latency end process boundary,0.5958333333333333
Exposure to COVID-19,place closure control strategy,0.65
Exposure to COVID-19,B cell receptor complex,0.636046511627907
Exposure to COVID-19,latency end temporal region,0.598936170212766
UnionTerritory,T cell receptor complex,0.6121621621621621
Anniversary,single-stranded RNA retrovirus,0.5963414634146341
Anniversary,pathogen birth process boundary,0.6404761904761905
Anniversary,double-stranded RNA virus,0.6166666666666667
Anniversary,negative-sense single-stranded RNA virus,0.5872549019607843
Anniversary,establishment of a clinically abnormal colony,0.575
Anniversary,T cell receptor complex,0.5382352941176471
Anniversary,incubation end temporal region,0.6207317073170732
Anniversary,positive-sense single-stranded RNA virus,0.5676470588235294
Anniversary,communicability end process boundary,0.6202127659574468
Anniversary,communicability end temporal region,0.5804347826086956
Anniversary,infection end temporal region,0.6
Anniversary,incubation end process boundary,0.6404761904761905
Anniversary,latency end process boundary,0.6551282051282051
Anniversary,pathogen birth temporal region,0.6207317073170732
Anniversary,B cell receptor complex,0.5382352941176471
Anniversary,latency end temporal region,0.6342105263157894
InfectedViaHealthcareWork,establishment of a clinically abnormal colony,0.6071428571428572
InfectedViaHealthcareWork,infected population,0.7
InfectedViaHealthcareWork,T cell receptor complex,0.5958333333333333
InfectedViaHealthcareWork,healthcare facility,0.6772727272727272
Dedicated Covid Health Centre (DCHC),COVID-19 mortality rate,0.6533898305084747
Dedicated Covid Health Centre (DCHC),infectious disease mortality rate,0.6384057971014493
Dedicated Covid Health Centre (DCHC),establishment of a clinically abnormal colony,0.6104938271604938
Dedicated Covid Health Centre (DCHC),COVID-19 incidence rate,0.6364406779661017
Dedicated Covid Health Centre (DCHC),complex infection,0.5820754716981132
Dedicated Covid Health Centre (DCHC),object aggregate,0.6038461538461539
Dedicated Covid Health Centre (DCHC),object,0.5452380952380953
Dedicated Covid Health Centre (DCHC),infection incidence rate profile,0.6411764705882353
Dedicated Covid Health Centre (DCHC),T cell receptor complex,0.6533898305084747
Dedicated Covid Health Centre (DCHC),immunoglobulin complex,0.553448275862069
Dedicated Covid Health Centre (DCHC),incubation end temporal region,0.6469696969696969
Dedicated Covid Health Centre (DCHC),infectious disease incidence rate,0.6528985507246376
Dedicated Covid Health Centre (DCHC),communicability end process boundary,0.6305555555555555
Dedicated Covid Health Centre (DCHC),communicability end temporal region,0.6330985915492958
Dedicated Covid Health Centre (DCHC),infection end temporal region,0.6346153846153847
Dedicated Covid Health Centre (DCHC),incubation end process boundary,0.6291044776119403
Dedicated Covid Health Centre (DCHC),latency end process boundary,0.621875
Dedicated Covid Health Centre (DCHC),SARS-CoV-2 incidence rate,0.630327868852459
Dedicated Covid Health Centre (DCHC),B cell receptor complex,0.6364406779661017
Dedicated Covid Health Centre (DCHC),macromolecular complex,0.5879310344827586
Dedicated Covid Health Centre (DCHC),active immunization against infectious agent,0.6125
Dedicated Covid Health Centre (DCHC),appearance of disorder,0.6051724137931035
Dedicated Covid Health Centre (DCHC),latency end temporal region,0.6404761904761905
Dedicated Covid Health Centre (DCHC),infection incidence rate,0.65
Gathering,infectious disease course,0.5382352941176471
Gathering,establishment of a clinically abnormal colony,0.5425925925925926
Gathering,infectious structure aggregate,0.5525641025641026
Gathering,coronavirus disease course,0.5357142857142857
Gathering,viral disease course,0.553448275862069
Gathering,object aggregate,0.61
Gathering,T cell receptor complex,0.54375
Gathering,COVID-19 disease course,0.54375
Gathering,function,0.6264705882352941
Gathering,herd immunity to infectious organism,0.5833333333333334
Gathering,coronavirus aggregate,0.5833333333333334
Gathering,virus aggregate,0.6166666666666667
Gathering,acute infectious disease course,0.575
Gathering,SARS-CoV-2 aggregate,0.5879310344827586
Gathering,disease course,0.5804347826086956
Gathering,viroid aggregate,0.61
Gathering,B cell receptor complex,0.5125
Gathering,acellular structure aggregate,0.581578947368421
Gathering,prion aggregate,0.6166666666666667
Gathering,chronic infectious disease course,0.5452380952380953
Gathering,action specification,0.6224137931034482
Gathering,long-term non-progressing infectious disease course,0.5666666666666667
